(ROOT
  (S
    (NP
      (NP (VBN Increased) (JJ interleukin-17) (NN production))
      (PP (IN via)
        (NP (DT a)
          (UCP
            (ADJP (JJ phosphoinositide) (JJ 3-kinase/Akt))
            (CC and)
            (NP
              (NP (JJ nuclear) (NN factor) (NN κB-dependent) (NN pathway))
              (PP (IN in)
                (NP
                  (NP (NNS patients))
                  (PP (IN with)
                    (NP (JJ rheumatoid) (NN arthritis) (NNP Abstract) (NNP Inflammatory)))))))
          (NNS mediators))))
    (VP (VBP have)
      (VP (VBN been)
        (VP (VBN recognized)
          (PP (IN as)
            (S
              (VP (VBG being)
                (ADJP (JJ important))
                (PP (IN in)
                  (NP
                    (NP (DT the) (NNS pathogenesis))
                    (PP (IN of)
                      (NP
                        (NP (JJ rheumatoid) (NN arthritis))
                        (PRN (-LRB- -LRB-)
                          (NP (NNP RA))
                          (-RRB- -RRB-))))))))))))
    (. .)))

(ROOT
  (S
    (NP (JJ Interleukin)
      (PRN (-LRB- -LRB-)
        (NP (NNP IL))
        (-RRB- -RRB-))
      (NNS -17))
    (VP (VBZ is)
      (NP
        (NP (DT an) (JJ important) (NN regulator))
        (PP (IN of)
          (NP
            (ADJP (JJ immune)
              (CC and)
              (JJ inflammatory))
            (NNS responses)))
        (, ,)
        (PP (VBG including)
          (NP
            (NP (DT the) (NN induction))
            (PP (IN of)
              (NP
                (NP (JJ proinflammatory) (NNS cytokines))
                (CC and)
                (NP (JJ osteoclastic) (NN bone) (NN resorption))))))))
    (. .)))

(ROOT
  (S
    (NP
      (NP (NN Evidence))
      (PP (IN for)
        (NP
          (NP (DT the) (NN expression)
            (CC and)
            (NN proinflammatory) (NN activity))
          (PP (IN of)
            (NP (NN IL-17))))))
    (VP (VBZ has)
      (VP (VBN been)
        (VP (VBN demonstrated)
          (PP
            (PP (IN in)
              (NP (NNP RA) (NNP synovium)))
            (CC and)
            (PP (IN in)
              (NP
                (NP (NN animal) (NNS models))
                (PP (IN of)
                  (NP (NNP RA)))))))))
    (. .)))

(ROOT
  (S
    (SBAR (IN Although)
      (S
        (NP
          (NP (DT some) (NNS cytokines))
          (PRN (-LRB- -LRB-)
            (ADJP (JJ IL-15)
              (CC and)
              (JJ IL-23))
            (-RRB- -RRB-)))
        (VP (VBP have)
          (VP (VBN been)
            (VP (VBN reported)
              (S
                (VP (TO to)
                  (VP (VB regulate)
                    (NP (NN IL-17) (NN production))))))))))
    (, ,)
    (NP
      (NP (DT the) (NN intracellular))
      (VP (VBG signaling)
        (NP
          (NP (NNS pathways))
          (SBAR
            (WHNP (WDT that))
            (S
              (VP (VB regulate)
                (NP (NN IL-17) (NN production))))))))
    (VP (VBP remain)
      (ADJP (JJ unknown)))
    (. .)))

(ROOT
  (S
    (PP (IN In)
      (NP (DT the) (JJ present) (NN study)))
    (, ,)
    (NP (PRP we))
    (VP (VBD investigated)
      (NP
        (NP (DT the) (NN role))
        (PP (IN of)
          (NP
            (NP (DT the)
              (ADJP
                (ADJP (JJ phosphoinositide) (JJ 3-kinase))
                (PRN (-LRB- -LRB-)
                  (NP (NNP PI3K))
                  (-RRB- -RRB-)))
              (NNP /) (NNP Akt) (NN pathway))
            (PP (IN in)
              (NP
                (NP (DT the) (NN regulation))
                (PP (IN of)
                  (NP (NN IL-17) (NN production))))))))
      (PP (IN in)
        (NP (NNP RA))))
    (. .)))

(ROOT
  (S
    (NP
      (NP
        (NP
          (NP (JJ Peripheral) (NN blood) (NN mononuclear) (NNS cells))
          (PRN (-LRB- -LRB-)
            (NP (NNP PBMC))
            (-RRB- -RRB-)))
        (PP (IN from)
          (NP
            (NP (NNS patients))
            (PP (IN with)
              (NP (NNP RA))))))
      (PRN (-LRB- -LRB-)
        (VP (VBN n)
          (S
            (VP (SYM =)
              (NP (CD 24)))))
        (-RRB- -RRB-)))
    (VP (VBD were)
      (VP
        (VP (VBN separated))
        (, ,)
        (VP
          (ADVP (RB then))
          (VBN stimulated)
          (PP (IN with)
            (NP
              (NP (JJ various) (NNS agents))
              (PP (VBG including)
                (NP
                  (NP
                    (NP
                      (ADJP
                        (ADJP (JJ anti-CD3))
                        (, ,)
                        (ADJP (JJ anti-CD28))
                        (, ,))
                      (NN phytohemagglutinin))
                    (PRN (-LRB- -LRB-)
                      (NP (NNP PHA))
                      (-RRB- -RRB-)))
                  (CC and)
                  (NP (JJ several) (JJ inflammatory) (NNS cytokines)))))))
        (CC and)
        (VP (VBZ chemokines))))
    (. .)))

(ROOT
  (S
    (NP (NN IL-17) (NNS levels))
    (VP (VBD were)
      (VP (VBN determined)
        (PP (IN by)
          (NP
            (NP (NN sandwich) (JJ enzyme-linked) (JJ immunosorbent) (NN assay)
              (CC and)
              (NN reverse) (NN transcription))
            (: --)
            (NP (NN polymerase) (NN chain) (NN reaction))))))
    (. .)))

(ROOT
  (S
    (NP
      (NP (DT The) (NN production))
      (PP (IN of)
        (NP (NN IL-17))))
    (VP (VBD was)
      (ADVP (RB significantly))
      (VP (VBN increased)
        (PP (IN in)
          (NP
            (NP (NNS cells))
            (VP (VBN treated)
              (PP (IN with)
                (NP (JJ anti-CD3) (NN antibody)))
              (PP (IN with)
                (CC or)
                (IN without)
                (NP
                  (NP (NN anti-CD28)
                    (CC and)
                    (NN PHA))
                  (PRN (-LRB- -LRB-)
                    (NP (NNP P) (NNP <) (NNP 0.05))
                    (-RRB- -RRB-)))))))))
    (. .)))

(ROOT
  (SINV
    (PP (IN Among))
    (VP (VBD tested)
      (NP
        (NP (NNS cytokines)
          (CC and)
          (NNS chemokines))
        (, ,)
        (NP (NN IL-15))
        (, ,)
        (NP (JJ monocyte) (NN chemoattractant) (NN protein-1))
        (CC and)
        (NP (NN IL-6))))
    (NP
      (NP (JJ upregulated) (NN IL-17) (NN production))
      (PRN (-LRB- -LRB-)
        (NP (NNP P) (NNP <) (NNP 0.05))
        (-RRB- -RRB-))
      (, ,)
      (SBAR (IN whereas)
        (S
          (NP (NN tumor))
          (VP (VBZ necrosis)
            (SBAR
              (S
                (NP
                  (ADJP (JJ factor-α) (, ,) (JJ IL-1β) (, ,) (JJ IL-18)
                    (CC or)
                    (JJ transforming))
                  (NN growth) (NNS factor-β))
                (VP (VBD did) (RB not))))))))
    (. .)))

(ROOT
  (S
    (S
      (NP (NNP IL-17))
      (VP (VBD was)
        (ADVP (RB also))
        (VP (VBN detected)
          (PP (IN in)
            (NP
              (NP (DT the) (NN PBMC))
              (PP (IN of)
                (NP
                  (NP (NNS patients))
                  (PP (IN with)
                    (NP (NNS osteoarthritis))))))))))
    (, ,)
    (CC but)
    (S
      (NP (PRP$ their) (NN expression) (NNS levels))
      (VP (VBD were)
        (ADJP (RB much) (JJR lower))
        (PP (IN than)
          (NP
            (NP (DT those))
            (PP (IN of)
              (NP (NNP RA) (NNP PBMC)))))))
    (. .)))

(ROOT
  (NP
    (NP
      (NP (JJ Anti-CD3) (NN antibody))
      (VP (VBN activated)
        (NP (DT the) (JJ PI3K/Akt) (NN pathway))))
    (: ;)
    (NP
      (NP (NN activation))
      (PP (IN of)
        (NP (DT this)
          (ADJP (RB pathway) (JJ resulted)
            (PP (IN in)
              (NP
                (NP (DT a) (JJ pronounced) (NN augmentation))
                (PP (IN of)
                  (NP (JJ nuclear) (NN factor))))))
          (NN κB)
          (PRN (-LRB- -LRB-)
            (NP (NNP NF-κB))
            (-RRB- -RRB-))
          (JJ DNA-binding) (NN activity))))
    (. .)))

(ROOT
  (S
    (NP
      (NP (NN IL-17) (NN production))
      (PP (IN by)
        (NP (NNP activated) (NNP RA) (NNP PBMC))))
    (VP (VBZ is)
      (ADVP (RB completely)
        (CC or)
        (RB partly))
      (VP (VBN blocked)
        (PP (IN in)
          (NP
            (NP
              (NP (DT the) (NN presence))
              (PP (IN of)
                (NP (DT the) (JJ NF-κB) (NN inhibitor) (NN pyrrolidine) (NN dithiocarbamate))))
            (CC and)
            (NP
              (NP (DT the) (JJ PI3K/Akt) (NN inhibitor) (NN wortmannin))
              (CC and)
              (NP (NNP LY294002)))))
        (, ,)
        (ADVP (RB respectively))))
    (. .)))

(ROOT
  (S
    (ADVP (RB However))
    (, ,)
    (NP
      (NP (NN inhibition))
      (PP (IN of)
        (NP (NN activator) (NN protein-1)
          (CC and)
          (NN extracellular))))
    (VP (VBD signal-regulated)
      (SBAR
        (S
          (NP (NN kinase) (CD 1/2))
          (VP (VBD did) (RB not)
            (VP (VB affect)
              (NP (NN IL-17) (NN production)))))))
    (. .)))

(ROOT
  (S
    (NP (DT These) (NNS results))
    (VP (VBP suggest)
      (SBAR (IN that)
        (S
          (NP
            (NP (NN signal) (NN transduction) (NNS pathways))
            (ADJP (JJ dependent)
              (PP (IN on)
                (NP (NNS PI3K/Akt)
                  (CC and)
                  (NNS NF-κB)))))
          (VP (VBP are)
            (VP (VBN involved)
              (PP (IN in)
                (NP
                  (NP (DT the) (NN overproduction))
                  (PP (IN of)
                    (NP
                      (NP (DT the) (JJ key) (JJ inflammatory) (NN cytokine) (NN IL-17))
                      (PP (IN in)
                        (NP (NNP RA))))))))))))
    (. .)))

(ROOT
  (S
    (NP
      (NP (NNP Introduction) (NNP Rheumatoid) (NNP arthritis))
      (PRN (-LRB- -LRB-)
        (NP (NNP RA))
        (-RRB- -RRB-)))
    (VP (VBZ is)
      (VP (VBN characterized)
        (PP (IN by)
          (NP
            (NP (NNS infiltrations))
            (PP (IN of)
              (NP (NNS macrophages)
                (CC and)
                (NN T) (NNS cells)))))
        (PP (IN into)
          (NP (DT the) (JJ joint) (, ,)
            (CC and)
            (NN synovial) (NN hyperplasia)))))
    (. .)))

(ROOT
  (S
    (NP
      (NP (JJ Proinflammatory) (NNS cytokines))
      (VP (VBN released)
        (PP (IN from)
          (NP (DT these) (NNS cells)))))
    (VP (VBP are)
      (VP (VBN known)
        (S
          (VP (TO to)
            (VP (VB be)
              (ADJP (JJ important)
                (PP (IN in)
                  (NP
                    (NP (DT the) (NN destruction))
                    (PP (IN of)
                      (NP
                        (NP (NNS joints))
                        (PP (IN in)
                          (NP (NNP RA) (NNP -LSB-) (CD 1) (NNS -RSB-)))))))))))))
    (. .)))

(ROOT
  (S
    (NP
      (NP (DT The) (JJ favorable) (JJ clinical) (NNS benefits))
      (VP (VBN obtained)
        (PP (IN with)
          (NP
            (NP (NNS inhibitors))
            (PP (IN of)
              (NP (NN tumor) (NNS necrosis)))))
        (S
          (VP (VB factor)
            (PRN
              (NP
                (NP (-LRB- -LRB-) (NNP TNF) (-RRB- -RRB-))
                (: -)
                (NP (NN α)))
              (-RRB- -RRB-))
            (CC and)
            (VB interleukin)
            (PRN (-LRB- -LRB-)
              (NP (NNP IL))
              (-RRB- -RRB-))
            (NP
              (NP (CD -1))
              (SBAR
                (S
                  (VP (VBP suggest)
                    (SBAR (IN that)
                      (S
                        (NP
                          (NP (DT the) (NN blockade))
                          (PP (IN of)
                            (NP (JJ key) (JJ inflammatory) (NNS cytokines))))
                        (VP (VBZ has)
                          (VP (VBN been)
                            (NP (DT the) (JJ important) (NN issue))))))))))
            (PP (IN in)
              (NP (DT the) (NN development)))
            (PP (IN of)
              (NP (JJ new) (JJ therapeutic) (NNS applications)))))))
    (VP (VBZ -LSB-)
      (NP (CD 2) (NNS -RSB-)))
    (. .)))

(ROOT
  (S
    (PP
      (NP (DT A) (JJ little))
      (IN over)
      (NP
        (NP (DT a) (NN decade))
        (ADVP (IN ago))))
    (, ,)
    (NP
      (NP (DT the) (NN primacy))
      (PP (IN of)
        (NP
          (NP (NNP T) (NNS cells))
          (PP (IN in)
            (NP
              (NP (DT the) (NNS pathogenesis))
              (PP (IN of)
                (NP
                  (NP (JJ autoimmune) (NN disease))
                  (PP (JJ such) (IN as)
                    (NP (NNP RA))))))))))
    (VP (VBD was)
      (VP (VBN undisputed)
        (SBAR (IN because)
          (S
            (NP (PRP they))
            (VP (VBP are)
              (NP
                (NP (DT the) (JJS largest) (NN cell) (NN population))
                (VP (VBG infiltrating)
                  (NP (DT the) (NN synovium)))))))))
    (. .)))

(ROOT
  (S
    (ADVP (RB However))
    (, ,)
    (NP
      (NP (DT a) (NN series))
      (PP (IN of)
        (NP (NNS studies))))
    (VP (VBD demonstrated)
      (NP
        (NP (NN paucity))
        (PP (IN of)
          (NP
            (NP (NNP T) (JJ cell-derived) (NNS cytokines))
            (PP (JJ such) (IN as)
              (NP (NNP IL-2)
                (CC and)
                (NNP interferon-γ))))))
      (PP (IN in)
        (NP
          (NP (DT the) (NNS joints))
          (PP (IN of)
            (NP (NNP RA)))))
      (, ,)
      (SBAR (IN whereas)
        (S
          (NP
            (NP
              (ADJP (JJ macrophage)
                (CC and)
                (JJ fibroblast))
              (NNS cytokines))
            (PP (VBG including)
              (NP (NNP IL-1) (, ,) (NNP IL-6) (, ,) (NNP IL-15) (, ,) (NNP IL-18)
                (CC and)
                (NNP TNF-α))))
          (VP (VBD were)
            (ADJP (JJ abundant)
              (PP (IN in)
                (NP (JJ rheumatoid) (NN synovium))))))))
    (. .)))

(ROOT
  (S
    (NP (DT This) (NN paradox))
    (VP (VBZ has)
      (VP (VBN questioned)
        (NP
          (NP (DT the) (NN role))
          (PP (IN of)
            (NP (NNP T) (NNS cells))))
        (PP (IN in)
          (NP
            (NP (DT the) (NNS pathogenesis))
            (PP (IN of)
              (NP (NNP RA) (NNP -LSB-) (NNP 3) (NNP -RSB-)))))))
    (. .)))

(ROOT
  (S
    (SBAR (IN Because)
      (S
        (S
          (NP (PRP we))
          (VP (VBP have)
            (VP
              (ADVP (RB already))
              (VBN demonstrated)
              (NP
                (NP
                  (NP (DT the) (VBN enhanced) (NN proliferation))
                  (PP (IN of)
                    (NP (JJ antigen) (JJ specific) (NNP T) (NNS cells))))
                (, ,)
                (ADVP (RB especially)
                  (PP (TO to)
                    (NP (NN type))))
                (NP (NNP II) (NNP collagen))))))
        (, ,)
        (CC and)
        (S
          (NP
            (NP (DT the) (NN skewing))
            (PP (IN of)
              (NP (NNP T))))
          (VP (VBP helper)
            (SBAR
              (S
                (NP
                  (NP (NN type) (CD 1))
                  (PRN (-LRB- -LRB-)
                    (NP (NNP Th1))
                    (-RRB- -RRB-)))
                (VP (VBZ cytokines)
                  (PP (IN in)
                    (NP (NNP RA) (NNP -LSB-) (CD 4) (NNS -RSB-))))))))))
    (, ,)
    (NP
      (NP (DT the) (NN role))
      (PP (IN of)
        (NP (NNP T) (NNS cells))))
    (VP (VBZ needs)
      (S
        (VP (TO to)
          (VP (VB be)
            (VP (VBN elucidated)
              (PP (IN in)
                (NP (JJ different) (NNS aspects))))))))
    (. .)))

(ROOT
  (S
    (NP (NNP IL-17))
    (VP (VBZ is)
      (NP
        (NP (CD one))
        (PP (IN of)
          (NP
            (NP (DT the) (JJ inflammatory) (NNS cytokines))
            (VP (VBN secreted)
              (ADVP (RB mainly))
              (PP (IN by)
                (NP (VBN activated) (NNP T) (NNS cells))))
            (, ,)
            (SBAR
              (WHNP (WDT which))
              (S
                (VP (MD can)
                  (VP (VB induce)
                    (ADJP (JJ IL-6)
                      (CC and)
                      (JJ IL-8))
                    (PP (IN by)
                      (NP
                        (NP (NNS fibroblasts))
                        (VP (VBG -LSB-)
                          (NP (CD 5) (NNS -RSB-)))))))))))))
    (. .)))

(ROOT
  (S
    (S
      (NP (DT This) (NN cytokine))
      (VP (VBZ is)
        (PP (IN of)
          (NP
            (NP
              (NP (NN interest))
              (PP (IN for)
                (NP (CD two) (JJ major) (NNS reasons))))
            (: :)
            (ADVP (RB first))))
        (, ,)
        (ADVP (RB similarly))
        (PP (TO to)
          (NP (NNP TNF-α)
            (CC and)
            (NNP IL-1)))))
    (, ,)
    (NP (NNP IL-17))
    (VP (VBZ has)
      (NP
        (NP (JJ proinflammatory) (NNS properties))
        (: ;)
        (S
          (NP (NN second))
          (, ,)
          (NP (PRP it))
          (VP (VBZ is)
            (VP (VBN produced)
              (PP (IN by)
                (S
                  (NP (NNP T) (NNS cells))
                  (VP (VBG -LSB-)
                    (NP (CD 6) (NNS -RSB-))))))))))
    (. .)))

(ROOT
  (S
    (NP (JJ Recent) (NNS observations))
    (VP (VBD demonstrated)
      (SBAR (IN that)
        (S
          (NP (NNP IL-17))
          (VP (MD can)
            (ADVP (RB also))
            (VP (VB activate)
              (NP (JJ osteoclastic) (NN bone) (NN resorption))
              (PP (IN by)
                (NP
                  (NP
                    (NP
                      (NP (DT the) (NN induction))
                      (PP (IN of)
                        (NP (NNP RANKL))))
                    (PRN (-LRB- -LRB-)
                      (NP
                        (NP (NN receptor) (NN activator))
                        (PP (IN of)
                          (NP (JJ nuclear) (NN factor) (NN κB) (NNP -LSB-) (NNP NF-κB) (NNP -RSB-)))
                        (VP (VBN ligand)))
                      (-RRB- -RRB-)))
                  (, ,)
                  (SBAR
                    (WHNP (WDT which))
                    (S
                      (VP (VBZ is)
                        (VP (VBN involved)
                          (PP (IN in)
                            (NP
                              (NP (JJ bony) (NN erosion))
                              (PP (IN in)
                                (NP (NNP RA) (NNP -LSB-) (CD 7) (NNS -RSB-))))))))))))))))
    (. .)))

(ROOT
  (S
    (NP (PRP It))
    (ADVP (RB also))
    (VP
      (VP (VBZ stimulates)
        (NP
          (NP
            (NP (DT the) (NN production))
            (PP (IN of)
              (NP
                (NP (NN IL-6)
                  (CC and)
                  (NN leukemia) (NN inhibitory) (NN factor))
                (PP (IN by)
                  (NP (NNS synoviocytes))))))
          (, ,)
          (CC and)
          (PP (IN of)
            (NP (NN prostaglandin)))
          (NP
            (NP (NNP E2))
            (CC and)
            (NP (JJ nitric) (NN oxide))))
        (PP (IN by)
          (NP (NNS chondrocytes))))
      (, ,)
      (CC and)
      (VP (VBZ has)
        (NP (DT the) (NN ability)
          (S
            (VP (TO to)
              (VP (VB differentiate)
                (CC and)
                (VB activate)
                (NP (DT the) (JJ dendritic) (NNS cells))
                (S
                  (VP (VBG -LSB-)
                    (NP (CD 8-10) (NNS -RSB-))))))))))
    (. .)))

(ROOT
  (S
    (S
      (NP
        (NP (NNS Levels))
        (PP (IN of)
          (NP
            (NP (NN IL-17))
            (PP (IN in)
              (NP (JJ synovial) (NNS fluids))))))
      (VP (VBD were)
        (ADJP
          (ADJP (RB significantly) (JJR higher))
          (PP (IN in)
            (NP
              (NP (NNS patients))
              (PP (IN with)
                (NP (NNP RA))))))
        (PP (IN than) (IN in)
          (NP
            (NP (NNS patients))
            (PP (IN with)
              (NP
                (NP (NNS osteoarthritis))
                (PRN (-LRB- -LRB-)
                  (NP (NNP OA))
                  (-RRB- -RRB-))))))))
    (, ,)
    (CC and)
    (S
      (NP (PRP it))
      (VP (VBD was)
        (VP (VBN produced)
          (PP (IN by)
            (NP (NNP CD4) (NNP +) (NNP T) (NNS cells)))
          (PP (IN in)
            (NP (DT the) (JJ synovium)
              (QP (CD -LSB-) (CD 11,12))
              (NNS -RSB-))))))
    (. .)))

(ROOT
  (S
    (NP
      (NP (NN IL-15))
      (, ,)
      (VP (VBN secreted)
        (PP (IN from)
          (NP (VBN activated) (NNS macrophages))))
      (, ,))
    (VP (VBZ has)
      (VP (VBN been)
        (VP
          (VP (VBN reported)
            (S
              (VP (TO to)
                (VP (VB be)
                  (NP
                    (NP (DT an) (JJ important) (NN trigger))
                    (PP (IN of)
                      (NP
                        (NP (NN IL-17) (NN production))
                        (PP (IN in)
                          (NP
                            (NP (CD RA) (JJ peripheral) (NN blood) (NN mononuclear) (NNS cells))
                            (PRN (-LRB- -LRB-)
                              (NP (NNP PBMC))
                              (-RRB- -RRB-)))))))
                  (PP (IN by)
                    (NP (NN cyclosporine)))))))
          (CC and)
          (VP (VBN steroid)
            (NP (JJ sensitive) (NNS pathways))
            (S
              (VP (VBG -LSB-)
                (NP (CD 13) (NNS -RSB-))))))))
    (. .)))

(ROOT
  (S
    (ADVP (RB Recently))
    (, ,)
    (NP
      (NP (NNP Happel))
      (CC and)
      (NP (NNS colleagues)))
    (ADVP (RB also))
    (VP (VBD showed)
      (SBAR (IN that)
        (S
          (NP (NNP IL-23))
          (VP (MD could)
            (VP (VB be)
              (NP
                (NP (DT an) (JJ efficient) (NN trigger))
                (PP (IN of)
                  (NP
                    (NP (NN IL-17) (NN production))
                    (PP (IN from)
                      (NP
                        (NP (DT both) (NNP CD4) (NNP +)
                          (CC and)
                          (NNP CD8) (NNP +) (NNP T) (NNS cells))
                        (VP (VBG -LSB-)
                          (NP (CD 14) (NNS -RSB-)))))))))))))
    (. .)))

(ROOT
  (S
    (SBAR (IN Although)
      (S
        (NP
          (NP (DT the) (NN contribution))
          (PP (IN of)
            (NP
              (NP (NN IL-17))
              (PP (IN in)
                (NP
                  (NP (JJ joint) (NN inflammation))
                  (PP (IN in)
                    (NP (NNP RA))))))))
        (VP (VBZ has)
          (VP (VBN been)
            (VP (VBN documented)
              (PP (IN in)
                (NP
                  (NP (JJR earlier) (NNS studies))
                  (VP (VBG -LSB-)
                    (NP (CD 12,15,16) (NNS -RSB-))))))))))
    (, ,)
    (NP
      (NP (DT the) (NN intracellular) (NN signal) (NN transduction) (NN pathway))
      (PP (IN for)
        (NP (NN IL-17) (NN production))))
    (VP (VBZ remains)
      (ADJP (JJ uncertain)))
    (. .)))

(ROOT
  (S
    (PP (IN In)
      (NP (DT the) (JJ present) (NN study)))
    (NP (PRP we))
    (VP (VBD used)
      (NP (JJ various) (NNS stimuli))
      (S
        (VP (TO to)
          (VP (VB investigate)
            (NP (NN IL-17) (NN production))
            (PP (IN in)
              (NP
                (NP (NNP PBMC))
                (PP (IN of)
                  (NP
                    (NP (NNS patients))
                    (PP (IN with)
                      (NP
                        (NP (NNP RA))
                        (CC and)
                        (NP (PRP$ its) (JJ signaling) (NN transduction) (NN pathway))))))))))))
    (. .)))

(ROOT
  (S
    (NP (PRP We))
    (VP (VBD found)
      (SBAR (IN that)
        (S
          (NP
            (NP (DT the) (NN intracellular))
            (VP (VBG signaling)
              (ADVP (RB pathway))
              (S
                (VP (VBG involving)
                  (NP
                    (NP
                      (NP (JJ phosphoinositide) (NN 3-kinase))
                      (PRN (-LRB- -LRB-)
                        (NP (NNP PI3K))
                        (-RRB- -RRB-)))
                    (PRN (: /)
                      (NP (NNP Akt)
                        (CC and)
                        (NNP NF-κB))))))))
          (VP (MD might)
            (VP (VB be)
              (VP (VBN involved)
                (PP (IN in)
                  (NP
                    (NP (DT the) (NN overproduction))
                    (PP (IN of)
                      (NP
                        (NP (DT the) (JJ key) (JJ inflammatory) (NN cytokine) (NN IL-17))
                        (PP (IN in)
                          (NP (NNP RA)))))))))))))
    (. .)))

(ROOT
  (S
    (NP (DT These) (NNS results))
    (VP (MD might)
      (VP (VB provide)
        (NP (JJ new) (NNS insights))
        (PP (IN into)
          (NP
            (NP
              (NP (DT the) (NNS pathogenesis))
              (PP (IN of)
                (NP (NNP RA))))
            (CC and)
            (NP
              (NP (JJ future) (NNS directions))
              (PP (IN for)
                (NP
                  (NP (JJ new) (JJ therapeutic) (NNS strategies))
                  (PP (IN in)
                    (NP (NNP RA))))))))))
    (. .)))

(ROOT
  (S
    (NP (NNS Materials)
      (CC and)
      (NNS methods))
    (VP (VBD Informed)
      (SBAR
        (S
          (NP (NN consent))
          (VP (VBD was)
            (VP (VBN obtained)
              (PP (IN from)
                (NP
                  (NP (CD 24) (NNS patients))
                  (PRN (-LRB- -LRB-)
                    (NP
                      (NP (CD 5) (NNS men))
                      (CC and)
                      (NP (CD 19) (NNS women)))
                    (-RRB- -RRB-))))
              (PP (IN with)
                (NP
                  (NP (NNP RA))
                  (SBAR
                    (WHNP (WP who))
                    (S
                      (VP (VBD fulfilled)
                        (NP
                          (NP (DT the) (CD 1987) (VBN revised) (NNS criteria))
                          (PP (IN of)
                            (NP (DT the) (NNP American) (NNP College)))
                          (PP (IN of)
                            (NP (JJ Rheumatology)
                              (PRN (-LRB- -LRB-)
                                (ADVP (RB formerly))
                                (NP (DT the) (NNP American) (NNP Rheumatism) (NNP Association))
                                (-RRB- -RRB-))
                              (JJ -LSB-) (CD 17) (NNS -RSB-))))))))))))))
    (. .)))

(ROOT
  (S
    (NP
      (NP (DT The) (NN age))
      (PP (IN of)
        (NP
          (NP (DT the) (NNS patients))
          (PP (IN with)
            (NP (NNP RA))))))
    (VP (VBD was)
      (NP
        (NP (CD 50)
          (ADJP
            (ADJP
              (QP (CD ±) (CD 8)))
            (PRN (-LRB- -LRB-)
              (NP (NNP mean) (NNP ±) (NNP SEM))
              (-RRB- -RRB-)))
          (NNS years))
        (PRN (-LRB- -LRB-)
          (NP
            (NP (NN range) (CD 23))
            (: --)
            (NP (CD 71) (NNS years)))
          (-RRB- -RRB-))))
    (. .)))

(ROOT
  (S
    (NP (DT All) (NNS medications))
    (VP (VBD were)
      (VP (VBN stopped)
        (PP
          (NP (CD 48) (NNS hours))
          (IN before)
          (NP (NN entry)))
        (PP (TO to)
          (NP (DT the) (NN study)))))
    (. .)))

(ROOT
  (S
    (NP (NNS Comparisons))
    (VP (VBD were)
      (VP (VBN made)
        (PP
          (PP (IN with)
            (NP
              (NP (CD 14) (NNS patients))
              (PP (IN with)
                (NP
                  (NP (NNP OA))
                  (PRN (-LRB- -LRB-)
                    (NP
                      (NP (CD 3) (NNS men))
                      (CC and)
                      (NP (CD 11) (NNS women)))
                    (-RRB- -RRB-))))))
          (CC and)
          (PP (IN with)
            (NP
              (NP (CD 14) (JJ healthy) (NNS controls))
              (PRN (-LRB- -LRB-)
                (NP
                  (NP (CD 3) (NNS men))
                  (CC and)
                  (NP (CD 11) (NNS women)))
                (-RRB- -RRB-))
              (SBAR
                (WHNP (WP who))
                (S
                  (VP (VBD had)
                    (NP (DT no) (JJ rheumatic) (NNS diseases))))))))))
    (. .)))

(ROOT
  (S
    (NP
      (NP (DT The) (JJ mean) (NNS ages))
      (PP (IN of)
        (NP
          (NP (DT the) (NNS patients))
          (PP (IN with)
            (NP
              (NP (NNP OA))
              (CC and)
              (NP (DT the) (JJ healthy) (NNS controls)))))))
    (VP (VBD were)
      (ADJP
        (ADJP
          (ADJP
            (NP (CD 50) (NNS ±))
            (NP (CD 8) (NNS years)))
          (PRN (-LRB- -LRB-)
            (NP
              (NP (NN range) (CD 34))
              (: --)
              (NP (CD 68) (NNS years)))
            (-RRB- -RRB-)))
        (CC and)
        (ADJP
          (ADJP
            (NP (CD 30) (NNS ±))
            (NP (CD 6) (NNS years)))
          (PRN (-LRB- -LRB-)
            (NP
              (NP (NN range) (CD 24))
              (: --)
              (NP (CD 57) (NNS years)))
            (-RRB- -RRB-)))))
    (. .)))

(ROOT
  (S
    (S
      (NP (JJ Informed) (NN consent))
      (VP (VBD was)
        (VP (VBN obtained))))
    (, ,)
    (CC and)
    (S
      (NP (DT the) (NN protocol))
      (VP (VBD was)
        (VP (VBN approved)
          (PP (IN by)
            (NP
              (NP (DT the) (NNP Catholic) (NNP University))
              (PP (IN of)
                (NP (NNP Korea) (NNP Human) (NNP Research) (NNP Ethics) (NNP Committee))))))))
    (. .)))

(ROOT
  (SINV
    (S
      (NP
        (NP (NNP Recombinant) (NNP IL-17))
        (, ,)
        (ADJP (JJ IL-18) (, ,) (JJ IL-15))
        (, ,))
      (VP (VBP monocyte)
        (S
          (NP
            (NP (JJ chemoattractant) (NN protein-1))
            (PRN (-LRB- -LRB-)
              (NP (NNP MCP-1))
              (-RRB- -RRB-))
            (, ,)
            (NP
              (NP (JJ macrophage) (JJ inflammatory) (NN protein))
              (PRN (-LRB- -LRB-)
                (NP (NNP MIP))
                (-RRB- -RRB-))
              (NP (CD -1) (NN α)))
            (, ,))
          (ADJP (JJ MIP-1β) (, ,) (JJ IL-6)
            (CC and)
            (JJ IL-8)))))
    (VP (VBD were)
      (VP (VBN purchased)
        (PP (IN from)
          (NP (NNP R)
            (CC &)
            (NNP D)))))
    (NP
      (NP (NNS systems))
      (PRN (-LRB- -LRB-)
        (NP (NNP Minneapolis))
        (, ,)
        (NP (NNP MN))
        (, ,)
        (NP (NNP USA))
        (-RRB- -RRB-)))
    (. .)))

(ROOT
  (NP
    (NP (JJ Recombinant) (JJ transforming) (NN growth) (NN factor))
    (PRN (-LRB- -LRB-)
      (NP (NNP TGF))
      (-RRB- -RRB-))
    (: -)
    (NP
      (NP (NN β))
      (SBAR
        (S
          (VP (VBD was)
            (VP (VBN purchased)
              (PP (IN from)
                (NP
                  (NP (NNP Peprotech))
                  (PRN (-LRB- -LRB-)
                    (NP (NNP London))
                    (, ,)
                    (NP (NNP UK))
                    (-RRB- -RRB-)))))))))
    (. .)))

(ROOT
  (S
    (NP (NNP Recombinant) (NNP TNF-α)
      (CC and)
      (NNP IL-1))
    (VP (VBD were)
      (VP (VBN purchased)
        (PP (IN from)
          (NP
            (NP (NNP Endogen) (NNP Inc.))
            (PRN (-LRB- -LRB-)
              (NP (NNP Cambridge))
              (, ,)
              (NP (NNP MA))
              (, ,)
              (NP (NNP USA))
              (-RRB- -RRB-))))))
    (. .)))

(ROOT
  (S
    (NP (NNP Cyclosporin) (NNP A))
    (VP (VBD was)
      (VP (VBN provided)
        (PP (IN by)
          (NP
            (NP (NNP Sandos) (NNP Ltd.))
            (PRN (-LRB- -LRB-)
              (NP (NNP Basel))
              (, ,)
              (NP (NNP Switzerland))
              (-RRB- -RRB-))))))
    (. .)))

(ROOT
  (S
    (NP
      (NP
        (NP (NNP Phytohemagglutinin))
        (PRN (-LRB- -LRB-)
          (NP (NNP PHA))
          (-RRB- -RRB-))
        (, ,)
        (NP
          (NP (JJ pyrrolidine) (NN dithiocarbamate))
          (PRN (-LRB- -LRB-)
            (NP (NNP PDTC))
            (-RRB- -RRB-))))
      (, ,)
      (ADJP (JJ rapamycin) (, ,) (JJ dexamethasone)
        (CC and)
        (JJ curcumin)))
    (VP (VBD were) (RB all)
      (VP (VBN obtained)
        (PP (IN from)
          (NP
            (NP (DT the) (NNP Sigma) (NNP Chemical) (NNP Co.))
            (PRN (-LRB- -LRB-)
              (NP (NNP St) (NNP Louis))
              (, ,)
              (NP (NNP MA))
              (, ,)
              (NP (NNP USA))
              (-RRB- -RRB-))))))
    (. .)))

(ROOT
  (S
    (NP
      (NP (JJ Anti-CD3) (JJ monoclonal) (NN antibody))
      (CC and)
      (NP (JJ anti-CD28) (JJ monoclonal) (NN antibody)))
    (VP (VBD were)
      (VP (VBN obtained)
        (PP (IN from)
          (NP
            (NP (NNP BD) (NNP Biosciences))
            (PRN (-LRB- -LRB-)
              (NP (NNP San) (NNP Diego))
              (, ,)
              (NP (NNP CA))
              (, ,)
              (NP (NNP USA))
              (-RRB- -RRB-))))))
    (. .)))

(ROOT
  (S
    (NP (NNP LY294002) (, ,) (NNP SB203580) (, ,) (NNP FK506) (, ,) (NNP wortmannin)
      (CC and)
      (NNP PD98059))
    (VP (VBD were)
      (VP (VBN obtained)
        (PP (IN from)
          (NP
            (NP (NNP Calbiochem))
            (PRN (-LRB- -LRB-)
              (NP (NNP Schwalbach))
              (, ,)
              (NP (NNP Germany))
              (-RRB- -RRB-))))))
    (. .)))

(ROOT
  (S
    (NP (NNP PBMC))
    (VP (VBD were)
      (VP (VBN prepared)
        (PP (IN from)
          (NP (JJ heparinized) (NN blood)))
        (PP (IN by)
          (NP
            (ADJP
              (ADJP (JJ Ficoll-Hypaque))
              (PRN (-LRB- -LRB-)
                (NP (NNP SG1077))
                (-RRB- -RRB-)))
            (JJ density-gradient) (NN centrifugation)))))
    (. .)))

(ROOT
  (S
    (NP (JJ Cell) (NNS cultures))
    (VP (VBD were)
      (VP (VBN performed)
        (SBAR (IN as)
          (S
            (VP (VBD described)
              (S
                (ADVP (RB previously))
                (VP (VBG -LSB-)
                  (NP (CD 18) (NNS -RSB-)))))))))
    (. .)))

(ROOT
  (SINV
    (S
      (PP (IN In)
        (NP (NN brief)))
      (, ,)
      (NP (DT the) (NN cell) (NNS suspensions))
      (VP (VBD were)
        (VP (VBN adjusted)
          (PP (TO to)
            (NP
              (NP (DT a) (NN concentration))
              (PP (IN of)
                (NP (CD 106/ml)))))
          (PP (IN in)
            (NP (NNP RPMI) (CD 1640) (NN medium))))))
    (VP (VBD supplemented)
      (PP (IN with)
        (NP (CD 10) (NN %))))
    (NP
      (NP (JJ fetal) (NN calf) (NN serum))
      (, ,)
      (NP
        (NP (CD 100) (JJ U/ml) (NN penicillin))
        (, ,)
        (NP (CD 100) (JJ mg/ml) (NN streptomycin))
        (CC and)
        (NP (CD 2) (NN mM) (NN L-glutamine))))
    (. .)))

(ROOT
  (S
    (NP
      (NP (JJ Cell) (NN suspension))
      (PRN (-LRB- -LRB-)
        (NP
          (QP (CD 1) (CD ml)))
        (-RRB- -RRB-)))
    (VP (VBD was)
      (VP
        (VP (VBN dispensed)
          (PP (IN into)
            (NP
              (NP (JJ 24-well) (JJ multi-well) (NNS plates))
              (PRN (-LRB- -LRB-)
                (NP (NNP Nunc))
                (, ,)
                (NP (NNP Roskilde))
                (, ,)
                (NP (NNP Denmark))
                (-RRB- -RRB-)))))
        (, ,)
        (CC and)
        (VP (VBN incubated)
          (PP (IN for)
            (NP
              (NP (CD 24) (NNS hours))
              (PP (IN at)
                (NP
                  (NP (CD 37) (NNP °) (NNP C))
                  (PP (IN in)
                    (NP
                      (ADJP (CD 5) (NN %))
                      (NN CO2))))))))))
    (. .)))

(ROOT
  (S
    (ADVP (RB Subsequently))
    (, ,)
    (S
      (NP
        (NP (JJ various) (NNS concentrations))
        (PP (IN of)
          (NP
            (NP (NN cyclosporin) (NN A))
            (PRN (-LRB- -LRB-)
              (NP
                (NP (CD 10))
                (: --)
                (NP (CD 500) (NN ng/ml)))
              (-RRB- -RRB-)))))
      (VP (VBD were)
        (VP (VBN added)
          (PP (TO to)
            (NP (DT the) (NN medium))))))
    (CC and)
    (S
      (NP (NNS cells))
      (VP (VBD were)
        (VP (VBN incubated)
          (PP (IN for)
            (NP (CD 24) (NNS hours))))))
    (. .)))

(ROOT
  (SINV
    (PP (TO To)
      (NP (DT each) (NN well)))
    (VP (VBD was)
      (VP (VBN added)))
    (NP
      (NP (NNP FK506))
      (, ,)
      (NP (NN rapamycin) (, ,) (NN curcumin) (, ,) (NN PDTC) (, ,) (NN LY294002) (, ,) (NN SB203580) (, ,) (NN PD98059) (, ,) (NN dexamethasone)
        (CC or)
        (NN wortmannin)))
    (. .)))

(ROOT
  (S
    (PP (IN After)
      (NP
        (NP (NN incubation))
        (PP (IN for)
          (NP (CD 24) (NNS hours)))
        (PRN (-LRB- -LRB-)
          (SBAR (IN unless)
            (S
              (ADVP (RB otherwise))
              (VP (VBD stated))))
          (-RRB- -RRB-))))
    (, ,)
    (NP (JJ cell-free) (NNS media))
    (VP (VBD were)
      (VP (VBN collected)
        (CC and)
        (VBN stored)
        (PP (IN at)
          (NP (NNP -20) (NNP °) (NNP C)))
        (PP (IN until)
          (NP (NN assayed)))))
    (. .)))

(ROOT
  (S
    (S
      (NP (DT All) (NNS cultures))
      (VP (VBD were)
        (VP (VBN set)
          (PRT (RP up))
          (PP (IN in)
            (NP (NN triplicate))))))
    (, ,)
    (CC and)
    (S
      (NP (NNS results))
      (VP (VBP are)
        (VP (VBN expressed)
          (PP (IN as)
            (NP (NN means) (NNP ±) (NNP SEM))))))
    (. .)))

(ROOT
  (S
    (NP (JJ Anti-CD4) (NNS microbeads))
    (VP (VBD were)
      (VP (VBN used)
        (ADVP (RB essentially))
        (SBAR (IN as)
          (S
            (S
              (VP (VBN recommended)
                (PP (IN by)
                  (NP
                    (NP (DT the) (NN manufacturer))
                    (PRN (-LRB- -LRB-)
                      (NP (NNP Miltenyi))
                      (-RRB- -RRB-))))))
            (VP (VBZ -LSB-)
              (NP (CD 19) (NNS -RSB-)))))))
    (. .)))

(ROOT
  (S
    (NP (NNP PBMC))
    (VP (VBD were)
      (VP (VBN resuspended)
        (PP (IN in)
          (NP
            (NP (CD 80) (NN μl))
            (PP (IN of)
              (NP (NNP FBS) (JJ staining) (NN buffer)))))))
    (. .)))

(ROOT
  (S
    (S
      (NP
        (NP (JJ Anti-CD4) (NNS microbeads))
        (PRN (-LRB- -LRB-)
          (NP
            (QP (CD 20) (CD μl)))
          (-RRB- -RRB-)))
      (VP (VBD were)
        (VP (VBN added)
          (CC and)
          (VBN incubated)
          (PP (IN for)
            (NP
              (NP (CD 15) (NN min))
              (PP (IN at)
                (NP (CD 6))))))))
    (: --)
    (S
      (NP
        (NP (CD 12) (JJ °) (NNP C.) (NNP Saturating) (NNS amounts))
        (PP (IN of)
          (NP (JJ fluorochrome-conjugated) (NNS antibodies))))
      (VP (VBD were)
        (VP (VBN added)
          (PP (IN for)
            (NP (DT a) (JJ further) (CD 10) (NNS min))))))
    (. .)))

(ROOT
  (S
    (NP (NNS Cells))
    (VP (VBD were)
      (VP
        (VP (VBN diluted)
          (PP (IN in)
            (NP
              (NP (CD 2.5) (NN ml))
              (PP (IN of)
                (NP (NNP FBS) (JJ staining) (NN buffer))))))
        (, ,)
        (VP (VBN pelleted))
        (, ,)
        (VP (VBN resuspended)
          (PP (IN in)
            (NP (CD 500) (NN μl))))
        (CC and)
        (VP
          (ADVP (RB magnetically))
          (VBN separated) (, ,)
          (PP (RB usually) (IN on)
            (NP
              (NP (DT an) (NNP AutoMACS) (NN magnet))
              (VP (VBN fitted)
                (PP (IN with)
                  (NP (DT a) (NNP MACS) (NNP MS) (NN column)))))))))
    (. .)))

(ROOT
  (S
    (NP
      (NP (NNP Flow-through))
      (CC and)
      (NP
        (QP (CD two) (CD 1))
        (JJ ml) (NNS washes)))
    (VP (VBD were)
      (VP (VBN collected)
        (PP (IN as)
          (NP (DT the) (JJ negative) (NN fraction)))))
    (. .)))

(ROOT
  (S
    (NP (JJ Enriched) (NNS cells))
    (VP (VBD were)
      (VP (VBN collected)
        (PP (IN in)
          (NP
            (NP (CD two) (CD 0.5) (JJ ml) (NNS aliquots))
            (PP (IN from)
              (NP (DT the) (NN column)))))
        (PP (IN after)
          (NP (NN removal)))
        (PP (IN from)
          (NP (DT the) (NN magnet)))))
    (. .)))

(ROOT
  (S
    (S
      (ADVP (RB Alternatively))
      (, ,)
      (NP (NNS cells))
      (VP (VBD stained)
        (PP (IN with)
          (ADJP (JJ anti-CD4)))))
    (: --)
    (S
      (NP (NN phycoerythrin))
      (VP (VBD were)
        (VP
          (VP (VBN washed))
          (, ,)
          (VP
            (ADVP (RB magnetically))
            (VBN labeled)
            (PP (IN with)
              (NP
                (NP (JJ anti-phycoerythrin) (NNS microbeads))
                (PRN (-LRB- -LRB-)
                  (NP
                    (NP (CD 20) (NN μl))
                    (VP (VBN added)
                      (PP (TO to)
                        (NP
                          (NP
                            (NP (CD 80) (NN μl))
                            (PP (IN of)
                              (NP (NN cell) (NN suspension))))
                          (: ;)
                          (NP
                            (NP (CD 15) (NN min))
                            (, ,)
                            (NP
                              (NP (CD 6) (: --) (CD 12))
                              (NP (NNP °) (NNP C))))))))
                  (-RRB- -RRB-)))))
          (, ,)
          (CC and)
          (VP
            (ADVP (RB magnetically))
            (VBN separated)
            (SBAR (IN as)
              (S
                (VP (VBD described)
                  (ADVP (RB above)))))))))
    (. .)))

(ROOT
  (S
    (NP
      (NP (DT The) (NN purity))
      (PP (IN of)
        (NP (NNS cells))))
    (VP (VBD was)
      (VP (VBN assessed)
        (PP (IN by)
          (NP
            (NP (NN flow) (JJ cytometric) (NN analysis))
            (PP (IN of)
              (NP (JJ stained) (NNS cells)))))
        (PP (IN on)
          (NP (DT a) (NNP FACS) (NNP Vantage) (NN sorter)))))
    (. .)))

(ROOT
  (S
    (NP
      (NP
        (NP (JJS Most))
        (PRN (-LRB- -LRB-)
          (NP
            (QP (JJR more) (IN than) (CD 97))
            (NN %))
          (-RRB- -RRB-)))
      (PP (IN of)
        (NP (DT the) (VBN isolated) (NNS cells))))
    (VP (VBD had)
      (NP (DT the) (NNP CD4) (NNP T) (NN cell) (NN marker)))
    (. .)))

(ROOT
  (S
    (NP
      (NP (NN IL-17))
      (PP (IN in)
        (NP (NN culture) (NNS supernatants))))
    (VP (VBD was)
      (VP (VBN measured)
        (PP (IN by)
          (NP (NN sandwich) (JJ enzyme-linked) (JJ immunosorbent) (NN assay)))
        (SBAR (IN as)
          (S
            (VP (VBD described)
              (ADVP (RB previously))
              (NP
                (QP (CD -LSB-) (CD 20))
                (NNS -RSB-)))))))
    (. .)))

(ROOT
  (S
    (PP (IN In)
      (NP (NN brief)))
    (, ,)
    (NP
      (NP (DT a) (JJ 96-well) (NN plate))
      (PRN (-LRB- -LRB-)
        (NP (NNP Nunc))
        (-RRB- -RRB-)))
    (VP (VBD was)
      (VP (VBN coated)
        (PP (IN with)
          (NP
            (NP (CD 4) (NN μg))
            (PRN (: /)
              (S
                (NP
                  (NP (JJ ml) (JJ monoclonal) (NNS antibodies))
                  (PP (IN against)
                    (NP
                      (NP
                        (NP (NN IL-17))
                        (PRN (-LRB- -LRB-)
                          (NP
                            (NP (NN R))
                            (CC &)
                            (NP (NNP D) (NNPS Systems)))
                          (-RRB- -RRB-)))
                      (PP (IN at)
                        (NP (CD 4))))))
                (NP (NNP °) (NNP C)))))
          (ADVP (RB overnight)))))
    (. .)))

(ROOT
  (S
    (PP (IN After)
      (S
        (VP (VBG blocking)
          (PP (IN with)
            (NP
              (NP (JJ phosphate-buffered)
                (ADJP
                  (NP (CD saline/1) (NN %))
                  (JJ bovine))
                (JJ serum) (NNS albumin))
              (PRN (-LRB- -LRB-)
                (NP (NNP BSA))
                (-RRB- -RRB-))))))
      (PRN (: /)
        (NP
          (NP (CD 0.05) (NN %))
          (VP (VBN Tween)
            (NP (CD 20))
            (PP (IN for)
              (NP
                (NP (CD 2) (NNS hours))
                (PP (IN at)
                  (NP (NN room) (NN temperature)))))
            (PRN (-LRB- -LRB-)
              (NP
                (NP (CD 22))
                (: --)
                (NP (CD 25) (NNP °) (NNP C)))
              (-RRB- -RRB-)))
          (, ,)
          (NP (NN test) (NNS samples))
          (CC and)
          (NP (DT the) (JJ standard) (JJ recombinant) (NN IL-17)))))
    (PRN (-LRB- -LRB-)
      (NP
        (NP (NN R))
        (CC &)
        (NP (NNP D) (NNPS Systems)))
      (-RRB- -RRB-))
    (VP (VBD were)
      (VP
        (VP (VBN added)
          (PP (TO to)
            (NP (DT the) (JJ 96-well) (NN plate))))
        (CC and)
        (VP (VBN incubated)
          (PP (IN at)
            (NP
              (NP (NN room) (NN temperature))
              (PP (IN for)
                (NP (CD 2) (NNS hours))))))))
    (. .)))

(ROOT
  (S
    (NP (NNS Plates))
    (VP (VBD were)
      (VP (VBN washed)
        (PP
          (NP (CD four) (NNS times))
          (PP (IN with)
            (NP
              (NP (JJ phosphate-buffered)
                (UCP
                  (NP (NN saline/Tween) (CD 20))
                  (, ,)
                  (CC and)
                  (ADVP (RB then))
                  (ADJP (JJ incubated)
                    (PP (IN with)
                      (NP (CD 500) (JJ ng/ml) (JJ biotinylated) (NN mouse) (NNS monoclonal)))))
                (NNS antibodies))
              (PP (IN against)
                (NP (NN IL-17)))))
          (PRN (-LRB- -LRB-)
            (NP
              (NP (NN R))
              (CC &)
              (NP (NNP D) (NNPS Systems)))
            (-RRB- -RRB-)))
        (PP (IN for)
          (NP
            (NP (CD 2) (NNS hours))
            (PP (IN at)
              (NP (NN room) (NN temperature)))))))
    (. .)))

(ROOT
  (S
    (PP (IN After)
      (S
        (VP (VBG washing))))
    (, ,)
    (NP
      (NP (NN streptavidin))
      (PRN (: --)
        (ADJP (JJ alkaline) (JJ phosphate))
        (: --)))
    (VP (VBP horseradish)
      (SBAR
        (S
          (NP
            (NP (JJ peroxidase) (NN conjugate))
            (PRN (-LRB- -LRB-)
              (NP (NNP Sigma))
              (-RRB- -RRB-)))
          (VP (VBD was)
            (VP
              (VP (VBN incubated)
                (PP (IN for)
                  (NP (CD 2) (NNS hours))))
              (, ,)
              (VP
                (ADVP (RB then))
                (VBN washed)
                (ADVP (RB again)))
              (CC and)
              (VP (VBN incubated)
                (PP (IN with)
                  (NP
                    (NP (CD 1) (JJ mg/ml) (JJ p-nitrophenyl) (NN phosphate))
                    (PRN (-LRB- -LRB-)
                      (NP (NNP Sigma))
                      (-RRB- -RRB-))
                    (VP (VBN dissolved)
                      (PP (IN in)
                        (NP (NN diethanolamine)
                          (PRN (-LRB- -LRB-)
                            (NP (NNP Sigma))
                            (-RRB- -RRB-))
                          (S
                            (VP (TO to)
                              (VP (VB develop)
                                (NP (DT the) (JJ color) (NN reaction))))))))))))))))
    (. .)))

(ROOT
  (S
    (NP (DT The) (NN reaction))
    (VP (VBD was)
      (VP (VBN stopped)
        (PP (IN by)
          (NP
            (NP (DT the) (NN addition))
            (PP (IN of)
              (NP (CD 1)))
            (SBAR
              (S
                (NP
                  (NP (NNP M) (NNP NaOH))
                  (CC and)
                  (NP
                    (NP (DT the) (JJ optical) (NN density))
                    (PP (IN of)
                      (NP (DT each) (NN well)))))
                (VP (VBD was)
                  (VP (VBN read)
                    (PP (IN at)
                      (NP (CD 405) (NN nm)))))))))))
    (. .)))

(ROOT
  (S
    (NP
      (NP (DT The) (JJR lower) (NN limit))
      (PP (IN of)
        (NP (NN IL-17) (NN detection))))
    (VP (VBD was)
      (ADJP
        (NP (CD 10))
        (JJ pg/ml)))
    (. .)))

(ROOT
  (S
    (NP
      (NP (JJ Recombinant) (JJ human) (NN IL-17))
      (VP (VBN diluted)
        (PP (IN in)
          (NP (NN culture) (NN medium)))))
    (VP (VBD was)
      (VP (VBN used)
        (PP (IN as)
          (NP (DT a) (NN calibration) (NN standard)))
        (, ,)
        (S
          (VP (VBG ranging)
            (PP (IN from)
              (NP (CD 10)))
            (PP (TO to)
              (NP (CD 2000) (NN pg/ml)))))))
    (. .)))

(ROOT
  (S
    (NP (DT A) (JJ standard) (NN curve))
    (VP (VBD was)
      (VP
        (VP (VBN drawn)
          (PP (IN by)
            (S
              (VP (VBG plotting)
                (NP (JJ optical) (NN density))
                (PP (IN against)
                  (NP
                    (NP (DT the) (NN log))
                    (PP (IN of)
                      (NP
                        (NP (DT the) (NN concentration))
                        (PP (IN of)
                          (NP (JJ recombinant) (NNS cytokines)))))))))))
        (, ,)
        (CC and)
        (VP (VBN used)
          (PP (IN for)
            (NP
              (NP (NN determination))
              (PP (IN of)
                (NP (NN IL-17)))))
          (PP (IN in)
            (NP (NN test) (NNS samples))))))
    (. .)))

(ROOT
  (S
    (NP (NNP PBMC))
    (VP (VBD were)
      (VP (VBN incubated)
        (PP (IN with)
          (NP
            (NP (JJ various) (NNS concentrations))
            (PP (IN of)
              (NP
                (NP (JJ anti-CD3))
                (PP (IN in)
                  (NP
                    (NP (DT the) (NN presence)
                      (CC or)
                      (NN absence))
                    (PP (IN of)
                      (NP
                        (NP (NNS inhibitors))
                        (PRN (-LRB- -LRB-)
                          (NP (NNP LY294002))
                          (, ,)
                          (NP (NNP PDTC))
                          (-RRB- -RRB-))))))))))))
    (. .)))

(ROOT
  (S
    (PP (IN After)
      (NP
        (NP (CD 16) (NNS hours))
        (PP (IN of)
          (NP (NN incubation)))))
    (, ,)
    (NP (NN mRNA))
    (VP (VBD was)
      (VP (VBN extracted)
        (PP (IN with)
          (NP
            (NP
              (NP (NNP RNAzol) (NNP B))
              (PRN (-LRB- -LRB-)
                (NP (NNP Biotex) (NNP Laboratories))
                (, ,)
                (NP (NNP Houston))
                (, ,)
                (NP (NNP TX) (, ,) (NNP USA))
                (-RRB- -RRB-)))
            (PP (IN in)
              (NP (NN accordance)))))
        (PP (IN with)
          (NP
            (NP (DT the) (NN manufacturer) (POS 's))
            (NNS instructions)))))
    (. .)))

(ROOT
  (S
    (NP
      (NP (JJ Reverse) (NN transcription))
      (PP (IN of)
        (NP
          (NP (CD 2) (NN μg))
          (PP (IN of)
            (NP (JJ total) (NN mRNA))))))
    (VP (VBD was)
      (VP (VBN performed)
        (PP (IN at)
          (NP
            (NP (CD 42) (NNP °) (NNP C))
            (VP (VBG using)
              (NP
                (NP (DT the) (NNP Superscript) (NNP ™) (JJ reverse) (NN transcription) (NN system))
                (PRN (-LRB- -LRB-)
                  (NP (NNP Takara))
                  (, ,)
                  (NP (NNP Shiga))
                  (, ,)
                  (NP (NNP Japan))
                  (-RRB- -RRB-))))))))
    (. .)))

(ROOT
  (S
    (NP
      (NP (NNP PCR) (NNP amplification))
      (PP (IN of)
        (NP (NN cDNA) (NNS aliquots))))
    (VP (VBD was)
      (VP (VBN performed)
        (PP (IN by)
          (S
            (VP (VBG adding)
              (NP
                (NP (CD 2.5) (NN mM) (NNS dNTPs))
                (, ,)
                (NP
                  (NP
                    (QP (CD 2.5) (CD U)))
                  (PP (IN of)
                    (NP
                      (NP (NNP Taq) (NNP DNA) (NNP polymerase))
                      (PRN (-LRB- -LRB-)
                        (NP (NNP Takara))
                        (-RRB- -RRB-)))))
                (CC and)
                (NP
                  (NP (CD 0.25) (NN μM))
                  (PP (IN of)
                    (NP (NN sense)
                      (CC and)
                      (NN antisense) (NNS primers))))))))))
    (. .)))

(ROOT
  (S
    (NP (DT The) (NN reaction))
    (VP (VBD was)
      (VP (VBN performed)
        (PP (IN in)
          (NP
            (NP
              (NP (NNP PCR) (NNP buffer))
              (PRN (-LRB- -LRB-)
                (NP
                  (NP (CD 1.5) (NN mM) (NNS MgCl2))
                  (, ,)
                  (NP (CD 50) (NN mM) (NNP KCl))
                  (, ,)
                  (NP (CD 10) (NN mM) (NNP Tris-HCl))
                  (, ,)
                  (NP (NN pH) (CD 8.3)))
                (-RRB- -RRB-)))
            (PP (IN in)
              (NP
                (NP (DT a) (JJ total) (NN volume))
                (PP (IN of)
                  (NP (CD 25) (NN μl)))))))))
    (. .)))

(ROOT
  (NP
    (NP
      (NP (DT The) (JJ following) (NN sense)
        (CC and)
        (NN antisense) (NNS primers))
      (SBAR (IN for)
        (S
          (NP (DT each) (NNS molecules))
          (VP (VBD were)
            (VP (VBN used))))))
    (: :)
    (NP
      (NP
        (NP
          (ADJP (JJ IL-17))
          (NN sense))
        (, ,)
        (NP (CD 5) (POS ')))
      (: -)
      (NP
        (NP (NNP ATG) (NNP ACT) (NNP CCT) (NNP GGG) (NNP AAG) (NNP ACC))
        (NP (NNP TCA) (NNP TTG-3) (POS ')))
      (: ;)
      (NP
        (NP
          (ADJP (JJ IL-17))
          (NN antisense))
        (, ,)
        (NP (CD 5) (POS ')))
      (: -)
      (NP
        (NP (NNP TTA) (NNP GGC) (NNP CAC) (NNP ATG) (NNP GTG) (NNP GAC))
        (NP (NNP AAT) (NNP CGG-3) (POS ')))
      (: ;)
      (NP
        (NP
          (ADJP
            (ADJP (JJ glyceraldehyde-3-phosphate) (JJ dehydrogenase))
            (PRN (-LRB- -LRB-)
              (NP (NNP GAPDH))
              (-RRB- -RRB-)))
          (NN sense))
        (, ,)
        (NP (CD 5) (POS ')))
      (: -)
      (NP
        (NP (NNP CGA) (NNP TGC) (NNP TGG) (NNP GCG) (NNP TGA))
        (NP (NNP GTA) (NNP C-3) (POS ')))
      (: ;)
      (NP
        (NP
          (ADJP (JJ GAPDH))
          (NN antisense))
        (, ,)
        (NP (CD 5) (POS ')))
      (: -)
      (NP
        (NP (NNP CGT) (NNP TCA) (NNP GCT) (NNP CAG) (NNP GGA))
        (NP (NNP TGA) (NNP CC-3) (POS '))))
    (. .)))

(ROOT
  (S
    (S
      (NP (NNS Reactions))
      (VP (VBD were)
        (VP (VBN processed)
          (PP (IN in)
            (NP
              (NP (DT a) (NNP DNA) (JJ thermal) (NN cycler))
              (PRN (-LRB- -LRB-)
                (NP (NNP Perkin-Elmer) (NNP Cetus))
                (, ,)
                (NP (NNP Norwalk))
                (, ,)
                (NP (NNP CT) (, ,) (NNP USA))
                (-RRB- -RRB-))))
          (PP (IN through)
            (NP
              (NP (NNS cycles))
              (PP (IN for)
                (NP
                  (NP (CD 30) (NNS s))
                  (PP (IN of)
                    (NP (NN denaturation)))))))
          (PP (IN at)
            (NP
              (NP (CD 94) (NNP °) (NNP C))
              (, ,)
              (NP
                (NP
                  (QP (CD 1) (CD min)))
                (PP (IN of)
                  (S
                    (VP (VBG annealing)
                      (PP (IN at)
                        (NP
                          (NP (CD 56) (NNP °) (NNP C))
                          (PP (IN for)
                            (NP (NNP GAPDH)
                              (CC and)
                              (NNP IL-17))))))))
                (, ,)
                (VP (VBN followed)
                  (PP (IN by)
                    (NP
                      (NP (CD 1) (NN min))
                      (PP (IN of)
                        (NP (NN elongation))))))
                (PP (IN at)
                  (NP
                    (NP (CD 72) (NNS °))
                    (SBAR
                      (S
                        (NP (NNP C.) (NNP PCR) (NNS rounds))
                        (VP (VBD were)
                          (VP (VBN repeated)
                            (PP (IN for)
                              (NP
                                (NP (CD 25) (NNS cycles))
                                (NP (DT each))))
                            (PP (IN for)
                              (NP (DT both) (NNP GAPDH)
                                (CC and)
                                (NNP IL-17)))))))))))))))
    (: ;)
    (S
      (NP (DT this))
      (VP (VBD was)
        (VP (VBN determined)
          (PP (IN as)
            (S
              (VP (VBG falling)
                (PP (IN within)
                  (NP
                    (NP (DT the) (JJ exponential) (NN phase))
                    (PP (IN of)
                      (NP
                        (NP (NN amplification))
                        (PP (IN for)
                          (NP (DT each) (NN molecule)))))))))))))
    (. .)))

(ROOT
  (S
    (NP
      (NP (DT The) (NN level))
      (PP (IN of)
        (NP (NN mRNA) (NN expression))))
    (VP (VBD was)
      (VP (VBN presented)
        (PP (IN as)
          (NP
            (NP (DT a) (NN ratio))
            (PP (IN of)
              (NP (NNP IL-17) (NNP PCR) (NN product)))))
        (PP (IN over)
          (NP (NNP GAPDH) (NN product)))))
    (. .)))

(ROOT
  (S
    (NP (NNP PBMC))
    (VP (VBD were)
      (VP (VBN incubated)
        (PP (IN with)
          (NP
            (NP
              (NP (JJ anti-CD3))
              (PRN (-LRB- -LRB-)
                (NP
                  (QP (CD 10) (CD μg))
                  (NN /) (NN ml))
                (-RRB- -RRB-)))
            (PP (IN in)
              (NP
                (NP (DT the) (NN presence)
                  (CC or)
                  (NN absence))
                (PP (IN of)
                  (NP
                    (NP (NNP LY294002))
                    (PRN (-LRB- -LRB-)
                      (NP
                        (QP (CD 20) (CD μM)))
                      (-RRB- -RRB-))))))))))
    (. .)))

(ROOT
  (S
    (PP (IN After)
      (NP
        (NP (NN incubation))
        (PP (IN for)
          (NP (CD 1) (NN hour)))))
    (, ,)
    (NP (JJ whole) (NN cell) (NNS lysates))
    (VP (VBD were)
      (VP
        (VP (VBN prepared)
          (PP (IN from)
            (NP
              (QP (RB about) (CD 107))
              (NNS cells)))
          (PP (IN by)
            (NP
              (NP (NN homogenization))
              (PP (IN in)
                (NP (DT the) (JJ lysis) (NN buffer))))))
        (, ,)
        (CC and)
        (VP (VBN centrifuged)
          (PP (IN at)
            (NP
              (NP (CD 14,000) (NN r.p.m.)
                (PRN (-LRB- -LRB-)
                  (NP (CD 19,000) (NNS g))
                  (-RRB- -RRB-)))
              (PP (IN for)
                (NP (CD 15) (NN min))))))))
    (. .)))

(ROOT
  (S
    (NP
      (NP (NN Protein) (NNS concentrations))
      (PP (IN in)
        (NP (DT the) (NNS supernatants))))
    (VP (VBD were)
      (VP (VBN determined)
        (PP (IN with)
          (NP
            (NP (DT the) (NNP Bradford) (NN method))
            (PRN (-LRB- -LRB-)
              (NP (NNP Bio-Rad))
              (, ,)
              (NP (NNP Hercules))
              (, ,)
              (NP (NNP CA) (, ,) (NNP USA))
              (-RRB- -RRB-))))))
    (. .)))

(ROOT
  (S
    (NP (NN Protein) (NNS samples))
    (VP (VBD were)
      (VP
        (VP (VBN separated)
          (PP (IN by)
            (NP
              (NP
                (ADJP (CD 10) (NN %))
                (NNP SDS))
              (: --)
              (NP (NNP PAGE)))))
        (CC and)
        (VP (VBN transferred)
          (PP (TO to)
            (NP
              (NP (DT a) (JJ nitrocellulose) (NN membrane))
              (PRN (-LRB- -LRB-)
                (NP (NNP Amersham) (NNP Pharmacia) (NNP Biotech))
                (, ,)
                (NP (NNP Uppsala))
                (, ,)
                (NP (NNP Sweden))
                (-RRB- -RRB-)))))))
    (. .)))

(ROOT
  (SINV
    (S
      (PP (IN For)
        (NP (JJ western) (NN hybridization)))
      (, ,)
      (NP (NNP membrane))
      (VP (VBD was)
        (VP (VBN preincubated)
          (PP (IN with)
            (NP
              (NP
                (ADJP (CD 0.1) (NN %))
                (JJ skimmed) (NN milk))
              (PP (IN in)
                (NP
                  (NP (JJ TBS-T) (NN buffer))
                  (PRN (-LRB- -LRB-)
                    (NP
                      (NP (CD 0.1) (NN %))
                      (NP
                        (NP (NNP Tween) (CD 20))
                        (PP (IN in)
                          (NP (JJ Tris-buffered) (NN saline)))))
                    (-RRB- -RRB-))))))
          (PP (IN at)
            (NP
              (NP (NN room) (NN temperature))
              (PP (IN for)
                (NP
                  (NP (CD 2) (NNS hours))
                  (, ,)
                  (ADVP (RB then))
                  (NP
                    (NP (JJ primary) (NNS antibodies))
                    (PP (IN against)
                      (NP
                        (NP (NNP Akt) (, ,) (JJ phosphorylated) (NNP Akt)
                          (CC and)
                          (NNP IκB-α))
                        (PRN (-LRB- -LRB-)
                          (NP (NNP Cell) (NNP Signaling) (NNP Technology) (NNP Inc.))
                          (, ,)
                          (NP (NNP Beverly))
                          (, ,)
                          (NP (NNP MA) (, ,) (NNP USA))
                          (-RRB- -RRB-))
                        (, ,)
                        (ADJP (JJ diluted)
                          (NP (CD 1:1000)))
                        (PP (IN in)
                          (NP
                            (ADJP (CD 5) (NN %))
                            (NNS BSA/TBS-T)))))))))))))
    (, ,)
    (VP (VBD were)
      (VP (VBN added)
        (CC and)
        (VBN incubated)
        (ADVP (RB overnight))
        (PP (IN at)
          (NP (CD 4)))))
    (NP (NNP °) (NNP C))
    (. .)))

(ROOT
  (S
    (PP (IN After)
      (S
        (VP (VBG washing)
          (NP (CD four) (NNS times))
          (PP (IN with)
            (NP (NNP TBS-T))))))
    (, ,)
    (NP (JJ horseradish) (JJ peroxidase-conjugated) (JJ secondary) (NNS antibodies))
    (VP (VBD were)
      (VP (VBN added)
        (CC and)
        (VBN allowed)
        (S
          (VP (TO to)
            (VP (VB incubate)
              (PP (IN for)
                (NP
                  (NP (CD 1) (NN hour))
                  (PP (IN at)
                    (NP (NN room) (NN temperature))))))))))
    (. .)))

(ROOT
  (S
    (PP (IN After)
      (NP (NNP TBS-T) (NNP washing)))
    (, ,)
    (NP (JJ hybridized) (NNS bands))
    (VP (VBD were)
      (VP (VBN detected)
        (PP (IN with)
          (NP
            (NP (DT the) (JJ enhanced) (JJ chemiluminescence)
              (PRN (-LRB- -LRB-)
                (NP (NNP ECL))
                (-RRB- -RRB-))
              (NN detection) (NN kit)
              (CC and)
              (NNP Hyperfilm-ECL) (NNS reagents))
            (PRN (-LRB- -LRB-)
              (NP (NNP Amersham) (NNP Pharmacia))
              (-RRB- -RRB-))))))
    (. .)))

(ROOT
  (S
    (NP (NNP Nuclear) (NNS proteins))
    (VP (VBD were)
      (VP (VBN extracted)
        (PP (IN from)
          (NP
            (QP (RB about) (CD 5) (CD ×))
            (QP (CD 106) (CD PBMC))))))
    (. .)))

(ROOT
  (S
    (S
      (NP (JJ Oligonucleotide) (NNS probes))
      (VP (VBG encompassing)
        (S
          (NP
            (NP (DT the) (JJ NF-κB) (VBG binding) (NN site))
            (PP (IN of)
              (NP
                (NP (DT the) (JJ human) (NN IL-17) (NN promoter))
                (-LRB- -LRB-)
                (NP (CD 5))
                ('' '))))
          (: -)
          (NP (NNP ATG) (NNP ACC) (NNP TGG) (NNP AAA) (NNP TAC) (NNP CCA) (NNP AAA) (NNP TTC-3) ('' '))
          (-RRB- -RRB-)
          (VP (VBD were)
            (VP (VBN generated)
              (PP (IN by)
                (NP (CD 5) (POS '))))))))
    (: -)
    (S
      (NP
        (NP (NN end) (NNS labeling))
        (PP (IN of)
          (NP (DT the) (NN sense))))
      (VP (VBD strand)
        (PP (IN with)
          (NP
            (NP (JJ -LSB-) (JJ γ-32P) (NN -RSB-) (NN dATP))
            (PRN (-LRB- -LRB-)
              (NP (NNP Amersham) (NNP Pharmacia))
              (-RRB- -RRB-))
            (CC and)
            (NP (JJ T4) (NN polynucleotide) (NN kinase))
            (PRN (-LRB- -LRB-)
              (NP (NNP TaKaRa))
              (-RRB- -RRB-))))))
    (. .)))

(ROOT
  (S
    (NP (NNP Unincorporated) (NNS nucleotides))
    (VP (VBD were)
      (VP (VBN removed)
        (PP (IN by)
          (NP
            (NP (NNP NucTrap) (NN probe) (NN purification) (NNS columns))
            (PRN (-LRB- -LRB-)
              (NP (NNP Stratagene))
              (, ,)
              (NP (NNP La) (NNP Jolla))
              (, ,)
              (NP (NNP CA) (, ,) (NNP USA))
              (-RRB- -RRB-))))))
    (. .)))

(ROOT
  (S
    (NP
      (NP (JJ Nuclear) (NNS extracts))
      (PRN (-LRB- -LRB-)
        (NP
          (NP (CD 2) (NN μg))
          (PP (IN of)
            (NP (NN protein))))
        (-RRB- -RRB-)))
    (VP (VBD were)
      (VP (VBN incubated)
        (PP (IN with)
          (NP
            (NP
              (NP (JJ radiolabeled) (NN DNA) (NNS probes))
              (PRN (-LRB- -LRB-)
                (NP
                  (NP (CD 10) (NN ng))
                  (: ;)
                  (NP (CD 100,000) (NN c.p.m.)))
                (-RRB- -RRB-)))
            (PP (IN for)
              (NP
                (NP (CD 30) (NN min))
                (PP (IN at)
                  (NP
                    (NP (NN room) (NN temperature))
                    (PP (IN in)
                      (NP
                        (NP (CD 20) (NN μl))
                        (PP (IN of)
                          (NP
                            (NP (VBG binding) (NN buffer))
                            (VP (VBG consisting)
                              (PP (IN of)
                                (NP (CD 20)))
                              (ADVP (RB mM))
                              (FRAG
                                (X
                                  (NP
                                    (NP (NNP Tris-HCl))
                                    (, ,)
                                    (NP (NN pH) (CD 7.9))
                                    (, ,)
                                    (NP (CD 50) (NN mM) (NNP KCl))
                                    (, ,)
                                    (NP (CD 1) (NN mM) (NN dithiothreitol))
                                    (, ,)
                                    (NP (CD 0.5) (NN mM) (NNP EDTA))
                                    (, ,)
                                    (NP
                                      (NP
                                        (ADJP (CD 5) (NN %))
                                        (NN glycerol))
                                      (, ,)
                                      (NP (CD 1) (NN mg/ml) (NNP BSA)))
                                    (, ,)
                                    (NP (CD 0.2) (NN %)))
                                  (NP (NNP Nonidet))
                                  (NP
                                    (NP (NNP P40))
                                    (CC and)
                                    (NP (CD 50) (NN ng))))
                                (: /)
                                (NP (NN μl) (NN poly))))))))))))
            (PRN (-LRB- -LRB-)
              (ADJP (JJ dI-dC))
              (-RRB- -RRB-))))))
    (. .)))

(ROOT
  (S
    (S
      (NP (NNS Samples))
      (VP (VBD were)
        (VP (VBN subjected)
          (PP (TO to)
            (NP (NNS electrophoresis)))
          (PP (IN on)
            (S
              (VP (VBG nondenaturing)
                (NP
                  (NP
                    (ADJP (CD 5) (NN %))
                    (NN polyacrylamide) (NNS gels))
                  (PP (IN in)
                    (NP
                      (NP
                        (QP (CD 0.5) (CD ×))
                        (JJ Tris-borate-EDTA) (NN buffer))
                      (PRN (-LRB- -LRB-)
                        (NP
                          (QP (CD pH) (CD 8.0)))
                        (-RRB- -RRB-)))))
                (PP (IN at)
                  (NP (CD 100)))))))))
    (NP (NNP V.) (NNP Gels))
    (VP (VBD were)
      (VP
        (VP (VBN dried)
          (PP (IN under)
            (NP (NN vacuum))))
        (CC and)
        (VP (VBN exposed)
          (PP (TO to)
            (NP (NNP Kodak) (NNP X-OMAT) (NN film))))
        (PP (IN at)
          (NP
            (NP (NNP -70) (NNP °) (NNP C))
            (PP (IN with)
              (NP (VBG intensifying) (NNS screens)))))))
    (. .)))

(ROOT
  (S
    (NP
      (NP (JJ Rabbit) (JJ polyclonal) (NNS antibodies))
      (PP (IN against)
        (NP (JJ NF-κB) (NNS subunits) (NNS p50) (, ,) (NNS p65)
          (CC and)
          (NN c-Rel))))
    (VP (VBD were)
      (PP (IN from)
        (NP
          (NP (NNP Santa) (NNP Cruz) (NNP Biotechnology))
          (PRN (-LRB- -LRB-)
            (NP (NNP Santa) (NNP Cruz))
            (, ,)
            (NP (NNP CA))
            (, ,)
            (NP (NNP USA))
            (-RRB- -RRB-)))))
    (. .)))

(ROOT
  (S
    (PP (IN For)
      (NP (NN cell) (NN viability) (NNS assays)))
    (, ,)
    (NP (DT the) (JJ trypan) (JJ blue) (JJ dye) (NN exclusion) (NN method))
    (VP (VBD was)
      (VP (VBN used)
        (S
          (VP (TO to)
            (VP (VB evaluate)
              (NP
                (NP (DT the) (NN potential))
                (PP (IN of)
                  (NP
                    (NP (JJ direct) (JJ cytotoxic) (NN effect))
                    (PP (IN of)
                      (NP
                        (NP (NNS inhibitors))
                        (PP (IN on)
                          (NP (NNS cells)))))))))))))
    (. .)))

(ROOT
  (S
    (PP (IN After)
      (NP
        (NP (NN incubation))
        (PP (IN for)
          (NP (CD 24) (NNS hours)))))
    (, ,)
    (S
      (NP (DT the) (NNS cells))
      (VP (VBD were)
        (VP (VBN harvested))))
    (CC and)
    (S
      (NP (DT the) (NN percentage) (NN cell) (NN viability))
      (VP (VBD was)
        (VP (VBN calculated)
          (PP (IN with)
            (NP
              (NP (DT the) (NN formula)
                (QP (CD 100) (CD ×)))
              (PRN (-LRB- -LRB-)
                (NP
                  (NP (NN number))
                  (PP (IN of)
                    (NP
                      (NP (JJ viable) (NN cells/number))
                      (PP (IN of)
                        (NP
                          (ADJP (DT both) (JJ viable)
                            (CC and)
                            (JJ dead))
                          (NNS cells))))))
                (-RRB- -RRB-))))
          (S
            (VP (VBG -LSB-)
              (NP (CD 21) (NNS -RSB-)))))))
    (. .)))

(ROOT
  (S
    (NP (NNP Data))
    (VP (VBP are)
      (VP (VBN expressed)
        (PP (IN as)
          (NP (NN means) (NNP ±) (NNP SEM)))))
    (. .)))

(ROOT
  (S
    (NP (NNP Statistical) (NN analysis))
    (VP (VBD was)
      (VP (VBN performed)
        (PP (IN with)
          (NP
            (NP
              (NP (NNP Student) (POS 's))
              (NN t-test))
            (PP (IN for)
              (NP (VBN matched) (NNS pairs)))))))
    (. .)))

(ROOT
  (S
    (NP (NNP P) (NNS values))
    (ADVP (RBR less)
      (PP (IN than)
        (NP (CD 0.05))))
    (VP (VBD were)
      (VP (VBN considered)
        (S
          (ADJP (JJ significant)))))
    (. .)))

(ROOT
  (S
    (S
      (NP (NNP Results) (NNP PBMC))
      (VP (VBD were)
        (VP (VBN separated)
          (CC and)
          (VBN cultured)
          (PP (IN with)
            (NP
              (NP
                (NP
                  (NP (NNP PHA))
                  (PRN (-LRB- -LRB-)
                    (NP
                      (QP (CD 5) (CD μg))
                      (NN /) (NN ml))
                    (-RRB- -RRB-)))
                (PP (IN from)
                  (NP
                    (NP (NNS patients))
                    (PP (IN with)
                      (NP (NNP RA))))))
              (, ,)
              (NP
                (NP (NNS patients))
                (PP (IN with)
                  (NP (NNP OA))))
              (, ,)
              (CC and)
              (NP (JJ age-matched) (JJ normal) (NNS controls)))))))
    (: ;)
    (S
      (NP (NN IL-17) (NNS levels))
      (VP (VBD were)
        (ADVP (RB then))
        (VP (VBN determined)
          (PP (IN in)
            (NP
              (NP (DT the) (NN culture) (NNS supernatants))
              (PRN (-LRB- -LRB-)
                (NP
                  (QP (CD Fig.) (CD 1)))
                (-RRB- -RRB-)))))))
    (. .)))

(ROOT
  (S
    (SBAR (IN Although)
      (S
        (NP
          (NP (DT the) (NNS amounts))
          (PP (IN of)
            (NP (JJ basal) (NN IL-17) (NN secretion))))
        (VP (VBD were) (RB not)
          (ADJP (JJ different)
            (PP (IN between)
              (NP
                (NP (NNP RA))
                (, ,)
                (NP (NNP OA))
                (CC and)
                (NP (JJ normal) (NNS controls))
                (PRN (-LRB- -LRB-)
                  (NP
                    (NP (CD 62))
                    (NP
                      (NP (NNP ±) (CD 31) (, ,) (CD 43))
                      (RRC
                        (NP
                          (QP (CD ±) (CD 19)
                            (CC and)
                            (CD 43) (CD ±) (CD 10))
                          (NN pg/ml))
                        (, ,)
                        (ADVP (RB respectively)))))
                  (-RRB- -RRB-))))))))
    (, ,)
    (NP
      (NP (DT the) (NN IL-17) (NN production))
      (VP (VBN stimulated)
        (PP (IN by)
          (NP (NNP PHA)))))
    (VP (VBD was)
      (ADJP
        (ADJP (RB significantly) (JJR higher))
        (PP (IN in)
          (NP (NNP RA) (NNP PBMC))))
      (PP (IN than) (IN in)
        (NP
          (NP
            (NP (DT those))
            (PP (IN from)
              (NP (NNP OA))))
          (CC and)
          (NP
            (NP (NNS controls))
            (PRN (-LRB- -LRB-)
              (NP
                (NP
                  (QP (CD 768) (CD ±))
                  (NNS 295))
                (PP (IN versus)
                  (NP
                    (ADJP
                      (QP (CD 463) (CD ±)))
                    (CD 211) (NN pg/ml) (NNP -LSB-) (NNP P) (NNP <) (CD 0.05) (NNS -RSB-)
                    (CC and)
                    (NNP 241) (NNP ±) (CD 29) (NN pg/ml) (NNP -LSB-) (NNP P) (NNP <) (CD 0.001) (NNS -RSB-))))
              (-RRB- -RRB-))))))
    (. .)))

(ROOT
  (S
    (SBAR (IN Because)
      (S
        (NP (NNP IL-17))
        (VP (VBD was)
          (VP
            (ADVP (RB already))
            (VBN known)
            (PP (IN from)
              (NP (JJR earlier) (NNS reports)))
            (S
              (VP (TO to)
                (VP (VB be)
                  (VP (VBN produced)
                    (ADVP (RB mainly))
                    (PP (IN by)
                      (NP (VBN activated) (NNP T) (NNS cells)))))))))))
    (, ,)
    (NP (PRP we))
    (VP (VBD investigated)
      (NP
        (NP (DT the) (NN effect))
        (PP (IN of)
          (NP (JJ different) (NNS concentrations)))
        (PP (IN of)
          (NP (JJ anti-CD3) (-LRB- -LRB-) (CD 1) (, ,) (CD 5)
            (CC and)
            (CD 10) (NN μg) (JJ /) (NNS ml)))
        (-RRB- -RRB-))
      (PP (IN as)
        (NP
          (NP (DT a) (NNP T) (NN cell) (NN activation))
          (, ,)
          (SBAR
            (WHNP (WDT which))
            (S
              (VP (VBD showed)
                (NP
                  (NP (DT a) (JJ dose-dependent) (NN increase))
                  (PP (IN in)
                    (NP
                      (NP (NN IL-17) (NNS levels))
                      (PRN (-LRB- -LRB-)
                        (NP
                          (NP (NNS data))
                          (VP (RB not) (VBN shown)))
                        (-RRB- -RRB-)))))))))))
    (. .)))

(ROOT
  (S
    (PP (IN On)
      (NP
        (NP (DT the) (NN basis))
        (PP (IN of)
          (NP (DT this)))))
    (, ,)
    (NP (PRP we))
    (VP (VBD chose)
      (NP (CD 10) (NN μg) (NN /) (NN ml))
      (PP (IN as)
        (NP (DT a) (NN stimulation) (NN concentration)))
      (PP (IN for)
        (ADJP (JJ anti-CD3))))
    (. .)))

(ROOT
  (S
    (S
      (SBAR (IN As)
        (S
          (VP (VBN shown)
            (PP (IN in)
              (NP (NNP Table) (CD 1) (, ,) (CD anti-CD3))))))
      (ADVP (RB significantly))
      (VP (VBD upregulated)
        (NP (NN IL-17) (NN production))
        (PRT (RP up))
        (PP (TO to)
          (NP (CD 3.7-fold)))))
    (, ,)
    (CC and)
    (S
      (NP
        (NP (DT the) (NN combination))
        (PP (IN of)
          (ADJP (JJ anti-CD28)
            (CC and)
            (JJ anti-CD3))))
      (VP (VBD produced)
        (ADJP
          (ADJP
            (ADJP (RBR more) (JJ IL-17))
            (PRN (-LRB- -LRB-)
              (NP
                (QP (RB approximately) (CD 1.3-1) (CD .5))
                (NN -) (NN fold))
              (-RRB- -RRB-)))
          (PP (IN than)
            (ADJP (JJ anti-CD3))))
        (ADVP (RB alone))))
    (. .)))

(ROOT
  (S
    (ADVP (RB Furthermore))
    (, ,)
    (SBAR
      (WHADVP (WRB when))
      (S
        (ADJP (JJ incubated)
          (PP (IN with)
            (NP
              (NP (NNP T) (NN cell) (NNS mitogens))
              (PP (JJ such) (IN as)
                (NP (NNP PHA))))))))
    (, ,)
    (NP (VBN increased) (NN IL-17) (NN production))
    (VP (VBD was)
      (ADJP (RBR more) (JJ pronounced)
        (PP (IN than)
          (PP (IN with)
            (NP
              (NP
                (ADJP (JJ anti-CD3)
                  (CC and)
                  (JJ anti-CD28)))
              (PRN (-LRB- -LRB-)
                (NP
                  (NP (CD 588) (NNS ±))
                  (NP
                    (NP
                      (NP (CD 85))
                      (PP (IN versus)
                        (NP
                          (NP (CD 211) (NNS ±))
                          (ADJP (CD 1) (JJ pg/ml)))))
                    (: ;)
                    (NP
                      (NP (NNP P) (NNP <))
                      (NP (CD 0.05)))))
                (-RRB- -RRB-)))))))
    (. .)))

(ROOT
  (S
    (SBAR (IN Because)
      (S
        (NP (NNP RA) (NNP PBMC))
        (VP (VBP include)
          (NP
            (NP (JJ several) (NN cell) (NNS types))
            (PP (IN in)
              (NP (NN addition))))
          (PP (TO to)
            (NP (NNP T) (NNS cells))))))
    (, ,)
    (NP
      (NP (DT some) (JJ inflammatory) (NNS cytokines))
      (VP (VBN released)
        (PP (IN from)
          (NP
            (NP (NNS macrophages))
            (CC and)
            (NP (JJ other) (NNS lymphocytes))))))
    (VP (MD might)
      (VP (VB have)
        (VP (VBN affected)
          (NP
            (NP (DT the) (NN production))
            (PP (IN of)
              (NP (NN IL-17))))
          (PP (IN from)
            (NP (NNP T) (NNS cells))))))
    (. .)))

(ROOT
  (S
    (S
      (VP (TO To)
        (VP (VB evaluate)
          (NP
            (NP (DT the) (NNS effects))
            (PP (IN of)
              (NP
                (NP (JJ inflammatory) (NNS cytokines))
                (VP (VBN released)
                  (PP (IN by)
                    (NP (VBN activated) (NN PBMC))))))))))
    (, ,)
    (NP (PRP we))
    (VP (VBD tested)
      (NP
        (NP (DT the) (NNS effects))
        (PP (IN of)
          (NP (JJ several) (NNS cytokines)
            (CC and)
            (NNS chemokines))))
      (PP (IN on)
        (NP (NN IL-17) (NN production))))
    (. .)))

(ROOT
  (S
    (NP (PRP We))
    (VP (VBD detected)
      (NP (DT an) (NN increase))
      (PP (IN in)
        (NP (NN IL-17) (NN level)))
      (PP (IN after)
        (NP
          (NP (NN stimulation))
          (PP (IN with)
            (NP
              (NP (NN IL-15))
              (PRN (-LRB- -LRB-)
                (NP (CD 10) (NN ng/ml))
                (-RRB- -RRB-))))))
      (, ,)
      (SBAR (IN whereas)
        (S
          (PP (IN with)
            (NP
              (NP
                (NP (NNS IL-1β))
                (PRN (-LRB- -LRB-)
                  (NP (CD 10) (NN ng/ml))
                  (-RRB- -RRB-)))
              (, ,)
              (NP
                (NP (NNP TNF-α))
                (PRN (-LRB- -LRB-)
                  (NP (CD 10) (NN ng/ml))
                  (-RRB- -RRB-)))
              (, ,)
              (NP
                (NP (NN IL-18))
                (PRN (-LRB- -LRB-)
                  (NP (CD 10) (NN ng/ml))
                  (-RRB- -RRB-)))
              (CC or)
              (NP
                (NP (NNP TGF-β))
                (PRN (-LRB- -LRB-)
                  (NP (CD 10) (NN ng/ml))
                  (-RRB- -RRB-)))))
          (NP
            (NP (DT the) (NNS levels))
            (PP (IN in)
              (NP (NN IL-17))))
          (VP (VBD were)
            (ADJP (JJ unchanged))
            (PRN (-LRB- -LRB-)
              (NP (NNP Fig.) (CD 2a))
              (-RRB- -RRB-))))))
    (. .)))

(ROOT
  (S
    (SBAR
      (WHADVP (WRB When))
      (S
        (VP (VBN treated)
          (PP (IN with)
            (NP
              (NP (NN MCP-1))
              (PRN (-LRB- -LRB-)
                (NP (CD 10) (NN ng/ml))
                (-RRB- -RRB-))
              (CC or)
              (NP (NN IL-6))
              (PRN (-LRB- -LRB-)
                (NP (CD 10) (NN ng/ml))
                (-RRB- -RRB-)))))))
    (, ,)
    (NP
      (NP (JJ significant) (NNS upregulations))
      (PP (IN of)
        (NP (NN IL-17) (NNS proteins))))
    (VP (VBD were)
      (ADJP
        (ADJP (JJ observed))
        (PRN (-LRB- -LRB-)
          (NP
            (NP (CD 62) (NNS ±))
            (NP
              (NP
                (QP (CD 42)
                  (CC and)
                  (CD 50) (CD ±) (CD 10)))
              (PP (IN versus)
                (NP
                  (NP
                    (NP (CD 31) (NNS ±))
                    (NP (CD 11) (NN pg/ml))
                    (, ,)
                    (ADVP (RB respectively)))
                  (: ;)
                  (NP
                    (NP (NNP P) (NNP <))
                    (NP (CD 0.05)))))))
          (-RRB- -RRB-)))
      (, ,)
      (SBAR (IN whereas)
        (S
          (NP (NN none))
          (VP (VBD was)
            (VP (VBN observed)
              (PP (IN with)
                (NP
                  (NP
                    (NP (NN IL-8))
                    (PRN (-LRB- -LRB-)
                      (NP (CD 10) (NN ng/ml))
                      (-RRB- -RRB-)))
                  (, ,)
                  (NP
                    (NP (NNS MIP-1α))
                    (PRN (-LRB- -LRB-)
                      (NP (CD 10) (NN ng/ml))
                      (-RRB- -RRB-)))
                  (CC or)
                  (NP
                    (NP
                      (NP (NNS MIP-1β))
                      (PRN (-LRB- -LRB-)
                        (NP (CD 10) (NN ng/ml))
                        (-RRB- -RRB-)))
                    (PRN (-LRB- -LRB-)
                      (NP (NNP Fig.) (CD 2b))
                      (-RRB- -RRB-))))))))))
    (. .)))

(ROOT
  (S
    (S
      (VP (VBG Having)
        (VP (VBN observed)
          (NP
            (NP (DT the) (VBN increased) (NN IL-17) (NN production))
            (PP (IN in)
              (NP (NNP RA) (NNP PBMC)))))))
    (, ,)
    (NP (PRP it))
    (VP (VBD was)
      (ADJP (JJ important)
        (S
          (VP (TO to)
            (VP (VB know)
              (SBAR
                (WHNP (WDT which))
                (S
                  (NP (NN signal) (NN transduction) (NNS pathways))
                  (VP (VBD were)
                    (VP (VBN involved))))))))))
    (. .)))

(ROOT
  (S
    (SBAR (IN As)
      (S
        (VP (VBN illustrated)
          (PP (IN in)
            (NP (NNP Fig.) (CD 3))))))
    (, ,)
    (NP
      (NP (DT an) (JJ significant) (NN decrease))
      (PP (IN in)
        (NP (JJ anti-CD3-induced) (NN IL-17) (NN production))))
    (VP (VBD was)
      (VP (VBN observed)
        (SBAR
          (WHADVP (WRB when))
          (S
            (VP (VBN co-incubated)
              (PP (IN with)
                (NP (JJ NF-κB) (NN inhibitor) (, ,) (NN PDTC)
                  (CC and)
                  (NN dexamethasone)))
              (PP (IN in)
                (NP (NN comparison)))
              (PP (IN with)
                (NP
                  (NP (JJ anti-CD3) (RB alone))
                  (PRN (-LRB- -LRB-)
                    (NP (CD 38) (NNS ±))
                    (NP
                      (NP
                        (QP (CD 5)
                          (CC and)
                          (CD 54) (CD ±) (CD 11)))
                      (PP (IN versus)
                        (NP
                          (NP
                            (NP (CD 98) (NNS ±))
                            (NP (CD 19) (NN pg/ml))
                            (, ,)
                            (ADVP (RB respectively)))
                          (: ;)
                          (NP
                            (NP (NNP P) (NNP <))
                            (NP (CD 0.05))))))
                    (-RRB- -RRB-)))))))))
    (. .)))

(ROOT
  (S
    (NP
      (NP (NN LY294002)
        (CC and)
        (NN wortmannin))
      (, ,)
      (PP (IN as)
        (NP
          (NP (DT an) (NN inhibitor))
          (PP (IN of)
            (NP (NNP PI3K)))))
      (, ,))
    (ADVP (RB also) (RB markedly))
    (VP (VBD inhibited)
      (NP (DT the) (JJ anti-CD3-induced) (NN IL-17) (NN production))
      (PP (IN in)
        (NP
          (NP (NNP RA) (NNP PBMC))
          (PRN (-LRB- -LRB-)
            (NP
              (NP
                (NP (CD 98) (NNP ±) (CD 19))
                (PP (IN versus)
                  (NP
                    (NP (CD 38)
                      (ADJP
                        (QP (CD ±) (CD 10)))
                      (JJ pg/ml) (NNP -LSB-) (NNP P) (NNP <) (CD 0.005) (NNS -RSB-))
                    (CC and)
                    (NP (CD 48)
                      (ADJP
                        (QP (CD ±) (CD 4)))
                      (JJ pg/ml) (NNP -LSB-) (NNP P) (NNP <) (CD 0.05) (NNS -RSB-)))))
              (, ,)
              (ADVP (RB respectively)))
            (-RRB- -RRB-)))))
    (. .)))

(ROOT
  (S
    (NP (DT The) (NN calcineurin))
    (VP (VBZ inhibitors)
      (SBAR
        (S
          (NP (NNS cyclosporin) (NNP A)
            (CC and)
            (NNP FK506))
          (ADVP (RB also))
          (VP (VBD downregulated)
            (SBAR
              (S
                (NP
                  (NP (DT the) (NN IL-17) (NN secretion))
                  (CONJP (RB as) (RB well) (IN as))
                  (NP
                    (NP (DT the) (JJ mitogen-activated) (NN protein) (NN kinase))
                    (PRN (-LRB- -LRB-)
                      (NP (NNP MAPK))
                      (-RRB- -RRB-))
                    (NP (JJ p38) (NN inhibitor) (NN SB203580))))
                (VP (VBD did) (, ,)
                  (SBAR (IN whereas)
                    (S
                      (NP (NN rapamycin)
                        (CC and)
                        (NN PD98059))
                      (VP (VBD had)
                        (NP
                          (NP (DT no) (NN effect))
                          (PP (IN on)
                            (NP
                              (NP (NN IL-17) (NNS levels))
                              (PRN (-LRB- -LRB-)
                                (NP
                                  (QP (CD Fig.) (CD 3)))
                                (-RRB- -RRB-)))))))))))))))
    (. .)))

(ROOT
  (S
    (S
      (VP (TO To)
        (VP (VB evaluate)
          (NP
            (NP (DT the) (NN possibility))
            (PP (IN of)
              (NP (JJ non-specific) (NN inhibition))))
          (PP (IN by)
            (NP
              (NP (DT the) (NN drug))
              (PP (IN at)
                (NP (JJ high) (NNS concentrations))))))))
    (, ,)
    (NP (PRP we))
    (VP (VBD observed)
      (NP
        (NP (DT the) (NN dose) (NN response))
        (PP (IN of)
          (NP (NNP PDTC)
            (CC and)
            (NNP LY294002))))
      (PP (IN for)
        (NP
          (NP (DT the) (NN inhibition))
          (PP (IN of)
            (NP (NN IL-17) (NN production)))))
      (PP (IN in)
        (NP (NNP PBMC))))
    (. .)))

(ROOT
  (S
    (NP (EX There))
    (VP (VBD were)
      (NP
        (NP (JJ dose-dependent) (NNS inhibitions))
        (PP (IN of)
          (NP
            (NP (NN IL-17) (NN production))
            (PP (IN with)
              (NP
                (NP (NN chemical) (NNS inhibitors))
                (PRN (-LRB- -LRB-)
                  (NP (NNP Fig.) (CD 4a))
                  (-RRB- -RRB-))))))))
    (. .)))

(ROOT
  (S
    (NP
      (NP (DT The) (JJ other) (NNS inhibitors))
      (PP (IN in)
        (NP
          (NP (NN addition))
          (PP (TO to)
            (NP (NNP PDTC)
              (CC and)
              (NNP LY294002))))))
    (VP (VBD showed)
      (NP
        (NP (DT the) (JJ same) (NN pattern))
        (PP (IN of)
          (NP (NN inhibition)))))
    (. .)))

(ROOT
  (S
    (NP
      (NP (JJ Cytotoxic) (NNS effects))
      (PP (IN on)
        (NP
          (NP (NNP PBMC))
          (PP (IN by)
            (NP
              (NP (DT the) (JJ chemical) (NNS inhibitors))
              (PP (IN at)
                (NP (JJ experimental) (NNS concentrations))))))))
    (VP (VBD were) (RB not)
      (VP (VBN observed)
        (PRN (-LRB- -LRB-)
          (NP (NNP Fig.) (CD 4b))
          (-RRB- -RRB-))))
    (. .)))

(ROOT
  (S
    (S
      (VP (TO To)
        (VP (VB see)
          (SBAR (IN whether)
            (S
              (NP (VBN enhanced) (NN IL-17) (NN production))
              (VP (MD could)
                (VP (VB be)
                  (VP (VBN regulated)
                    (PP (IN at)
                      (NP (DT a) (JJ transcriptional) (NN level)))))))))))
    (, ,)
    (NP
      (NP (JJ semi-quantatitive) (JJ reverse) (NN transcription))
      (: --)
      (NP (NN polymerase) (NN chain) (NN reaction)))
    (VP (VBD was)
      (VP (VBN performed)))
    (. .)))

(ROOT
  (S
    (S
      (NP (PRP We))
      (VP (VBD observed)
        (NP (DT a) (JJ dose-dependent) (NN increase))
        (PP (IN in)
          (NP (NN IL-17) (NN mRNA) (NNS transcripts)))
        (PP (IN after)
          (NP
            (NP (NN stimulation))
            (PP (IN with)
              (NP (CD anti-CD3)))))))
    (: ;)
    (S
      (NP (DT this))
      (VP (VBD was)
        (VP (VBN inhibited)
          (PP
            (PP (IN by)
              (NP (DT the) (NNP PI3K) (NN inhibitor) (NN LY294002)))
            (CC and)
            (PP (IN by)
              (NP
                (NP (DT the) (JJ NF-κB) (NN inhibitor) (NN PDTC))
                (PRN (-LRB- -LRB-)
                  (NP
                    (QP (CD Fig.) (CD 5)))
                  (-RRB- -RRB-))))))))
    (. .)))

(ROOT
  (S
    (S
      (VP (TO To)
        (VP (VB determine)
          (NP
            (NP (JJ downstream) (NN effector) (NNS molecules))
            (PP (IN of)
              (NP (DT the) (NNP PI3K) (NN pathway)))))))
    (, ,)
    (NP (PRP we))
    (VP (VBN evaluated)
      (NP
        (NP (DT the) (NN activation))
        (PP (IN of)
          (NP (NNP Akt))))
      (PP (IN by)
        (NP (JJ western) (VBG blotting))))
    (. .)))

(ROOT
  (S
    (SBAR (IN As)
      (S
        (VP (VBN shown)
          (PP (IN in)
            (NP (NNP Fig.) (CD 6)))
          (, ,)
          (PP (IN at)
            (NP
              (NP (CD 10) (NN min))
              (PP (IN of)
                (NP
                  (NP (NN incubation))
                  (PP (IN with)
                    (NP
                      (NP (JJ anti-CD3))
                      (PRN (-LRB- -LRB-)
                        (NP
                          (QP (CD 10) (CD μg))
                          (NN /) (NN ml))
                        (-RRB- -RRB-))
                      (CC or)
                      (NP (NNP LY294002))
                      (PRN (-LRB- -LRB-)
                        (NP
                          (QP (CD 20) (CD μM)))
                        (-RRB- -RRB-)))))))))))
    (, ,)
    (NP
      (NP (DT no) (NN difference))
      (PP (IN in)
        (NP
          (NP (DT the) (NNS amounts))
          (PP (IN of)
            (NP (JJ phosphorylated) (NN Akt))))))
    (VP (VBD was)
      (ADJP (JJ observed)))
    (. .)))

(ROOT
  (S
    (ADVP (RB However))
    (, ,)
    (PP (IN after)
      (NP
        (NP (CD 30) (NN min))
        (PP (IN of)
          (NP (NN incubation)))))
    (, ,)
    (VP (VBD phosphorylated)
      (SBAR
        (S
          (NP (NNP Akt))
          (VP (VBD increased)
            (NP
              (NP (-LRB- -LRB-)
                (QP (CD lane) (CD 2))
                (-RRB- -RRB-))
              (, ,)
              (CC and)
              (NP
                (NP (DT the) (NN effect))
                (PP (IN of)
                  (NP (NN inhibition)))))
            (PP (IN by)
              (NP
                (NP (NNP LY294002))
                (PRN (-LRB- -LRB-)
                  (NP
                    (QP (CD lane) (CD 3)))
                  (-RRB- -RRB-))
                (VP (VBN reached)
                  (NP
                    (NP (DT a) (NN peak))
                    (PP (IN at)
                      (NP (CD 60) (NN min))))
                  (, ,)
                  (S
                    (VP (VBG lasting)
                      (PP (TO to)
                        (NP
                          (NP (CD 120))
                          (: --)
                          (NP (CD 240) (NN min)))))))))))))
    (. .)))

(ROOT
  (S
    (PP (IN In)
      (NP (NN contrast)))
    (, ,)
    (NP
      (NP (JJ non-phosphorylated) (NN Akt))
      (CC and)
      (NP (NN β-actin)))
    (VP (VBD remained)
      (ADVP (JJ unchanged) (RB regardless))
      (PP (IN of)
        (NP (NN incubation) (NN time))))
    (. .)))

(ROOT
  (S
    (NP (NNP PHA) (, ,) (NNP concanavalin) (NNP A)
      (CC and)
      (NNP IL-15))
    (ADVP (RB also))
    (VP (VBD demonstrated)
      (NP (DT the) (JJ same) (NN effect))
      (PP (IN on)
        (NP (JJ phosphorylated) (NN Akt)))
      (SBAR (IN as)
        (S
          (VP (VBN shown)
            (PP
              (PP (IN with)
                (NP
                  (NP (JJ anti-CD3))
                  (, ,)
                  (SBAR
                    (WHNP (WDT which))
                    (S
                      (VP (VBD was)
                        (NP
                          (NP (DT an) (NN inhibition))
                          (PP (IN by)
                            (NP (NN wortmannin)
                              (CC and)
                              (NN PDTC)))))))))
              (CONJP (RB as) (RB well) (IN as))
              (PP (IN by)
                (NP
                  (NP (NNP LY294002))
                  (PRN (-LRB- -LRB-)
                    (NP
                      (NP (NNS data))
                      (VP (RB not) (VBN shown)))
                    (-RRB- -RRB-)))))))))
    (. .)))

(ROOT
  (S
    (S
      (VP (TO To)
        (VP (VB investigate)
          (S
            (S
              (VP
                (ADVP (RB further)
                  (NP (DT the) (NN intracellular)))
                (VBG signaling)
                (VP
                  (ADVP (RB pathway))
                  (VBN activated)
                  (PP (IN by)
                    (NP
                      (NP (JJ anti-CD3))
                      (PP (CC plus)
                        (NP (JJ anti-CD28) (, ,) (JJ concanavalin) (NNP A) (, ,) (NNP PHA)
                          (CC and)
                          (NNP IL-15))))))))
            (, ,)
            (CC and)
            (S
              (ADJP (JJ responsible)
                (PP (IN for)
                  (S
                    (VP (VBG inducing)
                      (NP (NN IL-17) (NN expression)))))))))))
    (, ,)
    (NP (PRP we))
    (VP (VBD performed)
      (NP
        (NP
          (NP (DT an) (JJ electrophoretic) (JJ mobility-shift) (NN assay))
          (PRN (-LRB- -LRB-)
            (NP (NNP EMSA))
            (-RRB- -RRB-)))
        (PP (IN of)
          (NP (JJ NF-κB) (NN recognition) (NNS sites))))
      (PP (IN in)
        (NP
          (NP (DT the) (NNS promoters))
          (PP (IN of)
            (NP (NN IL-17))))))
    (. .)))

(ROOT
  (S
    (SBAR (IN As)
      (S
        (VP (VBN shown)
          (PP (IN in)
            (NP (NNP Fig.) (CD 7a))))))
    (, ,)
    (NP
      (NP (JJ nuclear) (NNS extracts))
      (PP (IN from)
        (NP
          (NP (NNP RA) (NNP PBMC))
          (VP (VBN stimulated)
            (PP (IN with)
              (NP
                (NP (JJ anti-CD3) (NN plus) (NN anti-CD28))
                (PRN (-LRB- -LRB-)
                  (NP
                    (QP (CD lane) (CD 2)))
                  (-RRB- -RRB-))))))))
    (VP (VBD demonstrated)
      (NP
        (NP (VBN increased) (VBG binding))
        (PP (IN of)
          (NP (NNP NF-κB))))
      (PP (TO to)
        (NP
          (NP (NN IL-17) (NNS promoters))
          (PP (IN in)
            (NP (NN comparison)))))
      (PP (IN with)
        (NP
          (NP (DT that))
          (PP (IN of)
            (NP
              (NP (NNS controls))
              (PRN (-LRB- -LRB-)
                (NP
                  (QP (CD lane) (CD 1)))
                (-RRB- -RRB-)))))))
    (. .)))

(ROOT
  (S
    (NP (DT A) (NN supershift))
    (ADVP (RB assay))
    (VP (VBD demonstrated)
      (NP (JJ shifted) (NNS bands))
      (PP (IN in)
        (NP (CD p65)
          (CC and)
          (CD p50)))
      (PRN (-LRB- -LRB-)
        (NP (NNP lanes)
          (QP (CD 3)
            (CC and)
            (CD 4)))
        (-RRB- -RRB-))
      (PP (RB not) (IN in)
        (NP
          (NP (NN c-Rel))
          (PRN (-LRB- -LRB-)
            (NP
              (QP (CD lane) (CD 5)))
            (-RRB- -RRB-)))))
    (. .)))

(ROOT
  (S
    (S
      (PP (IN In)
        (NP (JJ normal) (NN PBMC)))
      (NP (DT the) (JJ same) (NN pattern))
      (VP (VBD was)
        (ADJP (JJ observed))))
    (, ,)
    (CC but)
    (S
      (NP
        (NP (DT the) (NN degree))
        (PP (IN of)
          (NP
            (NP (JJ NF-κB) (NN activation))
            (PP (IN by)
              (NP (JJ anti-CD3) (NN plus) (NNS anti-CD28))))))
      (VP (VBD was)
        (ADJP (RBR less) (JJ intense))
        (PP (IN than)
          (NP
            (NP (DT that))
            (PP (IN in)
              (NP
                (NP (NNP RA) (NNP PBMC))
                (PRN (-LRB- -LRB-)
                  (NP (NNP Fig.) (CD 7b))
                  (-RRB- -RRB-))))))))
    (. .)))

(ROOT
  (S
    (S
      (VP (TO To)
        (VP (VB confirm)
          (NP
            (NP (DT the) (NN link))
            (PP (IN between)
              (NP (JJ PI3K) (NN activity)
                (CC and)
                (NN NF-κB)))))))
    (, ,)
    (NP (PRP we))
    (VP (VBD performed)
      (S
        (NP (NNP EMSA))
        (VP (TO to)
          (VP (VB determine)
            (NP (DT the) (JJ NF-κB) (JJ binding) (NN activity))
            (PP (IN after)
              (NP
                (NP (NN treatment))
                (PP (IN with)
                  (NP (DT both) (NNP LY294002)
                    (CC and)
                    (NNP PDTC)))))))))
    (. .)))

(ROOT
  (S
    (NP (DT Both) (NNS agents))
    (VP (VBP block)
      (NP
        (NP (JJ NF-κB) (JJ DNA-binding) (NN activity))
        (PP (IN in)
          (NP
            (NP (DT the) (NN IL-17) (NN promoter))
            (PRN (-LRB- -LRB-)
              (NP (NNP Fig.) (CD 7c))
              (-RRB- -RRB-))))))
    (. .)))

(ROOT
  (S
    (NP
      (NP (JJ Western) (VBG blotting))
      (PP (IN for)
        (NP (NNP IκB-α))))
    (VP (VBD showed)
      (NP
        (NP (NN inhibition))
        (PP (IN of)
          (NP
            (NP (NN degradation))
            (PP (IN of)
              (NP (NNP IκB-α))))))
      (PP (IN by)
        (NP (NNP LY294002)
          (CC and)
          (NNP PDTC)))
      (PP (IN at)
        (NP
          (NP (DT the) (JJ same) (NN time))
          (PRN (-LRB- -LRB-)
            (NP (NNP Fig.) (CD 7c))
            (-RRB- -RRB-)))))
    (. .)))

(ROOT
  (S
    (PP (IN In)
      (NP (NN contrast)))
    (, ,)
    (NP (DT the) (NN AP-1))
    (ADVP (RB pathway))
    (VP (VBD was) (RB not)
      (VP (VBN activated)
        (PP (IN by)
          (NP (NN stimulation)))
        (PP (IN with)
          (NP
            (NP (JJ anti-CD3) (NN plus) (NN anti-CD28))
            (PRN (-LRB- -LRB-)
              (NP
                (NP (NNS data))
                (VP (RB not) (VBN shown)))
              (-RRB- -RRB-))))
        (, ,)
        (S
          (VP (VBG demonstrating)
            (SBAR (IN that)
              (S
                (NP (NNP NF-κB))
                (VP (VBZ is)
                  (NP
                    (NP (DT the) (JJ main) (NN intracellular))
                    (VP (VBG signaling)
                      (ADVP (RB pathway))
                      (PP (IN in)
                        (NP (NN IL-17) (NN production)))
                      (PP (IN by)
                        (NP (NNP activated) (NNP PBMC)))
                      (PP (IN from)
                        (NP
                          (NP (NNS patients))
                          (PP (IN with)
                            (NP (NNP RA))))))))))))))
    (. .)))

(ROOT
  (S
    (NP (NNP Discussion) (NNP IL-17))
    (VP (VBD was)
      (VP
        (ADVP (RB first))
        (VBN described)
        (PP (IN as)
          (NP (DT a) (NNP T) (NN cell) (NN product)))
        (PP (IN with)
          (NP (JJ proinflammatory) (NNS properties)))
        (S
          (VP (VBG -LSB-)
            (NP (CD 5,22) (NNS -RSB-))))))
    (. .)))

(ROOT
  (S
    (NP (NNP RA))
    (VP (VBZ is)
      (VP (VBN characterized)
        (PP (IN by)
          (NP
            (NP (NN hyperplasia))
            (PP (IN of)
              (NP
                (NP (JJ synovial) (NN lining) (NNS cells))
                (CC and)
                (NP (DT an) (JJ intense) (NN infiltration))))))
        (PP (IN by)
          (NP
            (NP (NN mononuclear) (NNS cells))
            (VP (VBG -LSB-)
              (NP (CD 23) (NNS -RSB-)))))))
    (. .)))

(ROOT
  (S
    (NP
      (NP (JJ Proinflammatory) (NNS cytokines))
      (PP (JJ such) (IN as)
        (NP (NNP IL-1)
          (CC and)
          (NNP TNF-α))))
    (VP (VBP are)
      (ADJP (JJ abundant)
        (PP (IN in)
          (NP (JJ rheumatoid) (NN synovium))))
      (, ,)
      (SBAR (IN whereas)
        (S
          (NP
            (NP (DT the) (NNP T) (JJ cell-derived) (NNS cytokines))
            (, ,)
            (NP (RB especially) (NN IL-4)
              (CC and)
              (NN interferon-γ))
            (, ,))
          (VP (VBP have)
            (ADVP (RB often))
            (VP (VBN proved)
              (ADJP (JJ difficult)
                (S
                  (VP (TO to)
                    (VP (VB detect)
                      (PP (IN in)
                        (NP (NNP RA) (NNP synovium) (NNP -LSB-) (NNP 24) (NNP -RSB-))))))))))))
    (. .)))

(ROOT
  (S
    (SBAR (IN Although)
      (S
        (NP (NNP T) (NNS cells))
        (VP (MD may)
          (VP (VB have)
            (NP
              (NP (DT a) (NN role))
              (PP (IN in)
                (NP
                  (NP (DT the) (NN augmentation))
                  (PP (IN of)
                    (NP (JJ rheumatoid) (JJ synovial) (NN inflammation))))))))))
    (, ,)
    (NP
      (NP (DT the) (NN lack))
      (PP (IN of)
        (NP (NNP T) (JJ cell-derived) (NNS cytokines))))
    (VP (VBZ has)
      (VP (VBN limited)
        (NP (PRP$ its) (NN importance))))
    (. .)))

(ROOT
  (S
    (PP (IN In)
      (NP (DT this) (NN respect)))
    (, ,)
    (NP (NNP IL-17))
    (VP (VBZ is)
      (VP (VBG appealing)
        (SBAR (IN because)
          (S
            (NP (PRP it))
            (VP (VBZ has)
              (VP (VBN been)
                (VP (VBN described)
                  (PP (IN as)
                    (NP (DT a) (NNP T) (JJ cell-derived) (NN cytokine)))
                  (PP (IN with)
                    (NP (JJ proinflammatory) (NNS properties))))))))))
    (. .)))

(ROOT
  (S
    (PP (IN In)
      (NP (PRP$ our) (NNS studies)))
    (, ,)
    (NP (PRP we))
    (VP (VBD tried)
      (S
        (VP (TO to)
          (VP (VB evaluate)
            (SBAR
              (SBAR
                (WHADVP (WRB how))
                (S
                  (NP (NN IL-17) (NN production))
                  (VP (VBZ is)
                    (VP (VBN regulated)
                      (PP (IN in)
                        (NP (NNP RA) (NNP PBMC)))))))
              (, ,)
              (CC and)
              (SBAR
                (WHNP (WDT which))
                (S
                  (VP (VBG signaling)
                    (S
                      (ADVP (RB pathway))
                      (NP (PRP it))
                      (VP (VBD used)))))))))))
    (. .)))

(ROOT
  (S
    (NP
      (NP (NNS Levels))
      (PP (IN of)
        (NP (NN IL-17))))
    (VP (VBD were)
      (VP (VBN found)
        (S
          (VP (TO to)
            (VP (VB be)
              (ADJP
                (ADJP (JJR higher))
                (PP (IN in)
                  (S
                    (VP (VBG RA)
                      (NP (JJ synovial)
                        (ADJP (JJ fluid)
                          (PP (IN than)
                            (PP (IN in)
                              (NP (NNP OA) (JJ synovial) (NN fluid)))))
                        (QP (CD -LSB-) (CD 15))
                        (NNS -RSB-)))))))))))
    (. .)))

(ROOT
  (S
    (ADVP (RB However))
    (, ,)
    (NP (EX there))
    (VP (VBP are)
      (NP
        (NP (JJ few) (NNS data))
        (ADJP (JJ available)
          (PP (IN on)
            (NP
              (NP (DT the) (NNS agents))
              (SBAR
                (WHNP (WDT that))
                (S
                  (VP (VB stimulate)
                    (NP
                      (NP (NN IL-17) (NN production))
                      (PP (IN in)
                        (NP (NNP RA))))
                    (, ,)
                    (SBAR (IN although)
                      (S
                        (NP
                          (NP (DT the) (JJS highest) (NN level))
                          (PP (IN of)
                            (NP (NN IL-17) (NN production))))
                        (VP (MD can)
                          (VP (VB be)
                            (VP (VBN achieved)
                              (PP (IN by)
                                (NP (JJ anti-CD3)
                                  (PRN (: /)
                                    (NP
                                      (NP (JJ anti-CD28) (NN stimulation))
                                      (PP (IN in)
                                        (NP (JJ healthy) (NNS individuals)))))
                                  (JJ -LSB-) (CD 25) (NNS -RSB-))))))))))))))))
    (. .)))

(ROOT
  (S
    (PP (IN In)
      (NP (PRP$ our) (NNS experiments)))
    (, ,)
    (NP
      (NP (NNP PHA) (RB as) (NNS mitogens))
      (, ,)
      (CONJP (RB as) (RB well) (IN as))
      (NP
        (NP (JJ anti-CD3) (NNS /))
        (ADJP (JJ anti-CD28)
          (PP (IN for)
            (S
              (VP (VBG signaling)
                (PP (IN through)
                  (NP (DT the) (NNP T) (NN cell) (NN receptor))))))))
      (, ,))
    (VP (VBD increased)
      (NP (NN IL-17) (NN production))
      (PP (IN from)
        (NP (NNP RA) (NNP PBMC)))
      (PP (IN in)
        (NP (DT a) (JJ dose-dependent) (NN manner))))
    (. .)))

(ROOT
  (S
    (NP (PRP We))
    (VP (VBD found) (, ,)
      (PP (IN by)
        (NP
          (NP (DT a) (NN cell) (NN proliferation) (NN assay))
          (PRN (-LRB- -LRB-)
            (NP
              (NP (NNS data))
              (VP (RB not) (VBN shown)))
            (-RRB- -RRB-))))
      (, ,)
      (SBAR (IN that)
        (S
          (NP
            (NP (DT this) (NN upregulation))
            (PP (IN of)
              (NP (NN IL-17))))
          (VP (MD might)
            (VP (VB be)
              (ADJP (JJ due))
              (PP
                (PP (TO to)
                  (NP (JJ increased) (JJ cellular) (NN activity)))
                (CONJP (RB rather) (IN than))
                (PP (TO to)
                  (NP (JJ cellular) (NN proliferation)))))))))
    (. .)))

(ROOT
  (S
    (S
      (NP (NNP IL-17))
      (VP (VBZ is)
        (VP (VBN produced)
          (ADVP (RB mainly))
          (PP (IN by)
            (NP (VBN activated) (NNP CD4) (NNP +) (NNP T) (NNS cells)))
          (, ,)
          (ADVP (RB especially))
          (PP (IN for)
            (NP (JJ Th1/Th0) (NNS cells))))))
    (, ,) (RB not)
    (S
      (NP (DT the) (JJ Th2) (NN phenotype))
      (VP (VBZ -LSB-)
        (NP (CD 26) (NNS -RSB-))))
    (. .)))

(ROOT
  (S
    (ADVP (RB However))
    (, ,)
    (NP (PRP it))
    (VP (MD can)
      (ADVP (RB also))
      (VP (VB be)
        (VP (VBN produced)
          (PP (IN by)
            (NP
              (NP (CD CD8) (NNP +) (NNP T) (NNS cells))
              (PP (IN via)
                (NP
                  (NP (DT an) (NN IL-23) (VBG triggering) (NN mechanism))
                  (PP (IN in)
                    (NP (JJ Gram-negative) (JJ pulmonary) (NN infection) (NNP -LSB-) (CD 14) (NNS -RSB-))))))))))
    (. .)))

(ROOT
  (S
    (PP (IN In)
      (NP (NN addition)))
    (, ,)
    (NP (NN IL-17) (NN production))
    (VP (VBD was)
      (VP
        (ADVP (RB significantly))
        (VBN augmented)
        (PP (IN by)
          (NP (NNP T) (NNS cells)))
        (S
          (VP (VBG recognizing)
            (NP
              (NP (NN type) (NNP II) (NNP collagen))
              (PP (IN in)
                (NP
                  (NP (DT a) (JJ collagen-induced) (NN arthritis) (NN model))
                  (VP (VBG -LSB-)
                    (NP (CD 27) (NNS -RSB-))))))))))
    (. .)))

(ROOT
  (S
    (NP
      (NP (DT A) (JJ complex) (NN interaction))
      (PP (IN between)
        (NP
          (NP (NNS cells))
          (PP (IN in)
            (NP (JJ inflamed) (NNP RA) (NNS joints))))))
    (VP (MD might)
      (VP (VB produce)
        (NP
          (NP (DT a) (NN variety))
          (PP (IN of)
            (NP
              (NP (JJ proinflammatory) (NNS cytokines)
                (CC and)
                (NNS chemokines))
              (, ,)
              (SBAR
                (WHNP (WDT which))
                (S
                  (ADVP (RB also))
                  (VP (VBP activate)
                    (NP
                      (NP (JJ other) (NNS cells))
                      (PP (IN in)
                        (NP (DT the) (NNS joints))))))))))))
    (. .)))

(ROOT
  (S
    (PP (IN For)
      (NP (NN example)))
    (, ,)
    (NP (NNP IL-17))
    (VP (VBZ stimulates)
      (S
        (NP (JJ rheumatoid) (NNS synoviocytes))
        (VP (TO to)
          (VP (VB secrete)
            (NP
              (NP (JJ several) (NNS cytokines))
              (PP (JJ such) (IN as)
                (NP
                  (NP (NN IL-6) (, ,) (NN IL-8)
                    (CC and)
                    (NN tumor) (NNS necrosis))
                  (VP (VBN factor-stimulated)
                    (NP
                      (NP (NN gene) (CD 6))
                      (CONJP (RB as) (RB well) (IN as))
                      (NP (NNP prostaglandin) (NNP E2)))
                    (PP (IN in)
                      (NP
                        (QP ($ vitro) (CD -LSB-) (CD 12,28,29))
                        (NNS -RSB-)))))))))))
    (. .)))

(ROOT
  (S
    (NP (EX There))
    (VP (VBP are)
      (PP (IN as)
        (NP (RB yet) (JJ few) (NNS data)))
      (ADJP (JJ available)
        (PP (IN on)
          (NP
            (NP (DT the) (NNS agents))
            (SBAR
              (WHNP (WDT that))
              (S
                (VP (VB stimulate)
                  (NP
                    (NP (NN IL-17) (NN production))
                    (PP (IN in)
                      (NP (NNP RA))))
                  (, ,)
                  (SBAR (IN although)
                    (S
                      (NP
                        (NP (DT some) (NNS cytokines))
                        (PRN (-LRB- -LRB-)
                          (ADJP (JJ IL-15)
                            (CC and)
                            (JJ IL-23))
                          (-RRB- -RRB-)))
                      (VP (VBP have)
                        (VP (VBN been)
                          (VP (VBN known)
                            (S
                              (VP (TO to)
                                (VP (VB regulate)
                                  (NP (NN IL-17) (NN production) (NNP -LSB-) (CD 13,14) (NNP -RSB-)))))))))))))))))
    (. .)))

(ROOT
  (S
    (NP (PRP We))
    (ADVP (RB therefore))
    (VP (VBD investigated)
      (NP
        (NP (DT the)
          (ADJP (IN in) (NN vitro))
          (NN production))
        (PP (IN of)
          (NP (NN IL-17))))
      (PP (IN in)
        (NP
          (NP (NNP RA) (NNP PBMC))
          (VP (VBG responding)
            (PP (TO to)
              (NP
                (NP
                  (NP (DT a) (NN variety))
                  (PP (IN of)
                    (NP (NNS cytokines/chemokines)
                      (CC and)
                      (NNS mitogens))))
                (CONJP (RB as) (RB well) (IN as))
                (NP
                  (NP
                    (NP (NNP T) (NN cell) (NN receptor))
                    (PRN (-LRB- -LRB-)
                      (NP (NNP TCR))
                      (-RRB- -RRB-)))
                  (VP (VBN ligation)
                    (S
                      (VP (VBG using)
                        (S
                          (NP (JJ anti-CD3) (NNS /))
                          (ADJP (JJ anti-CD28)))))))))))))
    (. .)))

(ROOT
  (S
    (NP (PRP$ Our) (NNS studies))
    (VP (VBD demonstrated)
      (SBAR (IN that)
        (S
          (NP
            (NP
              (NP (NN IL-15))
              (CC and)
              (NP (NN MCP-1)))
            (CONJP (RB as) (RB well) (IN as))
            (NP (NNP TCR) (NNP ligation)))
          (ADVP (RB significantly))
          (VP (VBD increased)
            (NP
              (NP (DT the) (NN production))
              (PP (IN of)
                (NP (NN IL-17))))
            (PP (IN in)
              (NP (NNP RA) (NNP PBMC)))))))
    (. .)))

(ROOT
  (S
    (S
      (VP (VBG Adding)
        (NP (NN IL-15)
          (CC or)
          (NN MCP-1))
        (PP (TO to)
          (NP (NNP TCR) (NN ligation)))))
    (VP (VBD augmented)
      (NP (NN IL-17) (NN production))
      (ADVP (RBR more) (RB markedly)))
    (. .)))

(ROOT
  (S
    (PP (IN In)
      (NP (NN contrast)))
    (, ,)
    (NP
      (NP (NN IL-1)
        (CC and)
        (NN TNF-α))
      (, ,)
      (SBAR
        (WHNP (WDT which))
        (S
          (VP (VBP are)
            (VP (VBN known)
              (S
                (VP
                  (VP (TO to)
                    (VP (VB have)
                      (NP (JJ proinflammatory) (NNS properties))))
                  (CC and)
                  (VP (TO to)
                    (VP (VB be)
                      (VP (VBN increased)
                        (PP (IN in)
                          (NP (NNP RA) (NNS joints))))))))))))
      (, ,))
    (VP (VBD did) (RB not)
      (VP (VB affect)
        (NP (NN IL-17) (NN production))))
    (. .)))

(ROOT
  (S
    (S
      (NP (PRP$ Our) (NNS data))
      (VP (VBD were)
        (ADJP (JJ consistent)
          (PP (IN with)
            (NP (DT a) (JJ recent) (NN report))))
        (SBAR (IN that)
          (S
            (NP (NNP IL-15))
            (VP (VBD triggered)
              (PP (IN in)
                (NP
                  (ADJP (NN vitro) (JJ IL-17))
                  (NN production)))
              (PP (IN in)
                (NP (NNP PBMC))))))))
    (, ,)
    (CC but)
    (S
      (NP (NNP TNF-α))
      (VP (VBD did) (RB not)
        (VP (VB do)
          (NP
            (QP (RB so) (CD -LSB-) (CD 13))
            (NNS -RSB-)))))
    (. .)))

(ROOT
  (S
    (SBAR (IN Although)
      (S
        (NP (EX there))
        (VP (VBD were)
          (NP (DT no) (NNS data))
          (SBAR (IN that)
            (S
              (NP (NNP MCP-1))
              (ADVP (RB directly))
              (VP (VBZ induces)
                (NP (NNP T) (NN cell) (NN activation))))))))
    (, ,)
    (NP (PRP it))
    (VP (MD might)
      (VP (VB exert)
        (NP (NNS effects))
        (ADVP (RB indirectly))
        (PP (IN on)
          (NP (NNP T) (NNS cells)))
        (PP (IN through)
          (NP
            (NP (DT the) (NN activation))
            (PP (IN of)
              (NP
                (NP (NNS monocytes/macrophages))
                (PP (IN in)
                  (NP (NNP PBMC) (NNS cultures)))))))))
    (. .)))

(ROOT
  (S
    (SBAR (IN As)
      (S
        (VP (VBD reported)
          (PP (IN for)
            (NP (JJ normal) (NNS individuals)))
          (S
            (VP (VBG -LSB-)
              (NP (CD 25) (NNS -RSB-)))))))
    (, ,)
    (NP
      (NP (NNP T) (NN cell) (NN activation))
      (PP (IN through)
        (NP (JJ anti-CD3) (JJ /) (NN anti-CD28))))
    (ADVP (RB also))
    (VP (VBZ increases)
      (NP
        (NP (NN IL-17) (NN induction))
        (PP (IN in)
          (NP (NNP RA) (NNP PBMC)))))
    (. .)))

(ROOT
  (S
    (SBAR (IN Although)
      (S
        (NP
          (NP (DT the) (JJ signaling) (NN pathway))
          (PP (IN for)
            (NP
              (NP (DT the) (NN induction))
              (PP (IN of)
                (NP
                  (NP (NNS cytokines/chemokines))
                  (PP (IN by)
                    (NP (NN IL-17))))))))
        (VP (VBZ has)
          (VP (VBN been)
            (VP (VBN documented)
              (ADVP (RB widely)
                (NP
                  (QP (CD -LSB-) (CD 8,30,31))
                  (NNS -RSB-))))))))
    (, ,)
    (NP (DT no) (NNS data))
    (VP (VBP have)
      (VP (VBN been)
        (ADJP (JJ available)
          (PP (IN on)
            (SBAR
              (WHADVP (WRB how))
              (S
                (NP (NN IL-17) (NN production))
                (VP (MD can)
                  (VP (VB be)
                    (VP (VBN regulated)
                      (PP (IN by)
                        (NP (JJ certain) (JJ signaling) (NNS pathways))))))))))))
    (. .)))

(ROOT
  (S
    (PP (IN By)
      (S
        (VP (VBG using)
          (NP (NN signal) (NN transduction) (NNS inhibitors)))))
    (, ,)
    (NP (PRP we))
    (ADVP (RB therefore))
    (VP (VBD examined)
      (SBAR
        (WHNP (WDT which))
        (S
          (S
            (VP (VBG signaling)
              (ADVP (RB pathway))))
          (VP (VBD was)
            (ADVP (RB mainly))
            (VP (VBN involved)
              (PP (IN in)
                (NP
                  (NP (DT the) (NN induction))
                  (PP (IN of)
                    (NP (NN IL-17)))))
              (PP (IN in)
                (NP (NNP RA) (NNP PBMC))))))))
    (. .)))

(ROOT
  (S
    (NP (PRP We))
    (VP (VBD identified)
      (SBAR (IN that)
        (S
          (NP
            (NP (JJ anti-CD3-induced) (NN IL-17) (NN production))
            (PP (IN in)
              (NP (NNP RA) (NNP PBMC))))
          (VP (VBD was)
            (ADVP (RB significantly))
            (VP (VBN hampered)
              (PP (IN by)
                (NP
                  (NP (DT the) (JJ PI3K) (NN inhibitor) (NN LY294002))
                  (CC and)
                  (NP (DT the) (JJ NF-κB) (NN inhibitor) (NN PDTC))))
              (PP (TO to)
                (NP
                  (NP (JJ comparable) (NNS levels))
                  (PP (IN of)
                    (NP (JJ basal) (NN production)))))
              (PP (IN without)
                (NP (NN stimulation))))))))
    (. .)))

(ROOT
  (S
    (NP (PRP We))
    (ADVP (RB also))
    (VP (VBD found)
      (SBAR (IN that)
        (S
          (NP (JJ anti-CD3-induced) (NN IL-17) (NN production))
          (VP (VBD was)
            (VP (VBN downregulated)
              (PP (IN by)
                (NP
                  (NP (DT the) (NN addition))
                  (PP (IN of)
                    (NP
                      (NP (NNP SB203580))
                      (, ,)
                      (NP (DT a) (JJ p38) (NN MAPK) (NN inhibitor)))))))))))
    (. .)))

(ROOT
  (S
    (NP (PRP It))
    (VP (VBZ is)
      (ADJP (JJ interesting))
      (SBAR (IN that)
        (S
          (NP
            (NP (DT a) (NN series))
            (PP (IN of)
              (NP (NN evidence))))
          (VP (VBZ supports)
            (NP
              (NP (NN crosstalk))
              (PP (IN between)
                (NP (CD NF-κB)
                  (CC and)
                  (CD p38))))))))
    (. .)))

(ROOT
  (S
    (PP (IN In)
      (NP (NNS myocytes)))
    (, ,)
    (S
      (NP (NNP IκB) (NNP kinase-β))
      (VP (VBZ is)
        (VP (VBN activated)
          (PP (IN by)
            (NP (CD p38) (NNS -LSB-)
              (QP (CD 32) (CD -RSB-)))))))
    (, ,)
    (CC and)
    (S
      (NP (DT the) (VBN activated) (NNS p38))
      (VP (MD can)
        (VP (VB stimulate)
          (NP (NNS NF-κB))
          (PP (IN by)
            (NP
              (NP (DT a) (NN mechanism))
              (VP (VBG involving)
                (NP
                  (NP
                    (ADJP (JJ histone) (JJ acetylase))
                    (JJ p300/CREB-binding) (NN protein) (NNS -LSB-))
                  (ADJP (CD 33) (JJ -RSB-)))))))))
    (. .)))

(ROOT
  (S
    (NP (PRP$ Our) (NNS results))
    (VP (VBD revealed)
      (SBAR (IN that)
        (S
          (NP (JJ p38) (NN MAPK) (NN activation))
          (VP (VBD was) (RB not)
            (VP (VBN affected)
              (PP (IN by)
                (NP (NNP LY294002)))
              (, ,)
              (SBAR (IN whereas)
                (S
                  (NP (JJ NF-κB) (JJ binding) (NN activity))
                  (VP (VBD was)
                    (VP (VBN decreased)
                      (PP (IN by)
                        (NP
                          (NP (NNP LY294002))
                          (, ,)
                          (SBAR
                            (WHNP (WDT which))
                            (S
                              (VP (VBD provided)
                                (NP (DT the) (NN evidence))
                                (PP (IN for)
                                  (NP
                                    (NP (DT a) (JJ p38) (NN MAPK))
                                    (ADJP (RB pathway) (JJ independent))
                                    (PP (IN of)
                                      (NP (JJ PI3K) (NN activation)))))))))))))))))))
    (. .)))

(ROOT
  (S
    (NP
      (NP (DT The) (JJ direct) (NN relationship))
      (PP (IN between)
        (NP (CD p38)
          (CC and)
          (CD NF-κB)))
      (PP (IN for)
        (NP (NN IL-17) (NN production))))
    (VP (VBZ needs)
      (S
        (VP (TO to)
          (VP (VB be)
            (VP (VBN studied)
              (PP (IN in)
                (NP (JJ future) (NNS experiments))))))))
    (. .)))

(ROOT
  (S
    (NP
      (NP (DT The) (NN search))
      (PP (IN for)
        (NP
          (NP (DT a) (JJ downstream) (NN pathway))
          (PP (IN of)
            (NP (NNP PI3K))))))
    (VP (VBD seemed)
      (S
        (VP (TO to)
          (VP (VB have)
            (NP
              (NP (DT a) (JJ maximal) (NN response))
              (PP (IN of)
                (NP (NNP Akt) (NN activation))))
            (PP (IN at)
              (NP
                (NP (CD 1) (NN hour))
                (CC and)
                (NP
                  (NP (DT a) (JJ gradual) (NN loss))
                  (PP (IN of)
                    (NP (NN activity))))))
            (PP (IN at)
              (NP (CD 2) (NNS hours)))))))
    (. .)))

(ROOT
  (S
    (NP
      (NP (DT The) (NN fact))
      (SBAR (IN that)
        (S
          (NP (NNP Akt))
          (VP (VBZ is)
            (VP (VBN phosphorylated)
              (PP (IN upon)
                (NP (JJ anti-CD3) (NN stimulation))))))))
    (VP (VBZ suggests)
      (NP
        (NP (DT the) (JJ possible) (NN involvement))
        (PP (IN of)
          (NP (NNP PI3K))))
      (PP (IN in)
        (NP
          (NP (DT the) (NN induction))
          (PP (IN of)
            (NP
              (NP (NN IL-17))
              (PP (IN in)
                (NP (NNP RA))))))))
    (. .)))

(ROOT
  (S
    (PP (IN In)
      (NP
        (NP (NN view))
        (PP (IN of)
          (NP
            (NP (DT the) (NN fact))
            (SBAR (IN that)
              (S
                (NP (NNP NF-κB))
                (VP (VBD was)
                  (ADVP (RB also))
                  (VP (VBN activated)
                    (PP (IN by)
                      (NP
                        (NP (JJ anti-CD3) (NNS /))
                        (ADJP (JJ anti-CD28) (, ,) (JJ IL-15)
                          (CC or)
                          (JJ mitogens))))
                    (PP (IN in)
                      (NP (PRP$ our) (NNS experiments)))))))))))
    (, ,)
    (NP (PRP it))
    (VP (VBZ is)
      (ADJP
        (ADJP (RBS most) (JJ likely))
        (SBAR (IN that)
          (S
            (NP (DT the) (JJ NF-κB) (NN pathway))
            (VP (VBZ is)
              (ADVP (RB also))
              (VP
                (ADVP (RB actively))
                (VBN involved)
                (PP (IN in)
                  (NP
                    (NP (DT the) (NN induction))
                    (PP (IN of)
                      (NP
                        (NP (NN IL-17))
                        (PP (IN in)
                          (NP (NNP RA) (NNP PBMC)))))))))))))
    (. .)))

(ROOT
  (S
    (PP (IN In)
      (NP (NN contrast)))
    (, ,)
    (NP
      (NP (DT the) (NNP AP-1) (NN signal) (NN transduction) (NN pathway))
      (, ,)
      (NP
        (NP (DT another) (JJ important) (JJ signaling) (NN pathway))
        (PP (IN for)
          (NP (NNS cytokines/chemokines))))
      (, ,))
    (VP (VBD was) (RB not)
      (VP (VBN activated)
        (PP (IN in)
          (NP
            (NP (PRP$ our) (NNS experiments))
            (PRN (-LRB- -LRB-)
              (NP
                (NP (NNS data))
                (VP (RB not) (VBN shown)))
              (-RRB- -RRB-))))))
    (. .)))

(ROOT
  (S
    (SBAR (IN Although)
      (S
        (NP
          (NP (NNP PI3K))
          (CC and)
          (NP
            (NP (PRP$ its) (JJ downstream) (JJ kinase) (NN Akt))
            (PP (IN in)
              (NP
                (NP (NN association))
                (PP (IN with)
                  (NP (NNP NF-κB)))))))
        (VP (VBP have)
          (VP (VBN been)
            (VP (VBN reported)
              (S
                (VP (TO to)
                  (VP (VB deliver)
                    (NP
                      (NP (VBG activating) (NNS signals))
                      (PP (IN in)
                        (NP (JJ many) (NN cell) (NNS types))))))))))))
    (, ,)
    (NP
      (NP (DT the) (NNS data))
      (PP (IN on)
        (NP
          (NP (DT the) (NN signal))
          (VP (VBG inducing)
            (NP (NN IL-17))))))
    (VP (VBP are)
      (VP (VBG lacking)))
    (. .)))

(ROOT
  (S
    (NP (PRP$ Our) (NNS data))
    (ADVP (RB clearly))
    (VP (VBD demonstrated)
      (SBAR (IN that)
        (S
          (NP
            (NP (NNS PI3K/Akt))
            (CC and)
            (NP (JJ resultant) (JJ NF-κB) (NN activation)))
          (VP (MD could)
            (VP (VB be)
              (NP
                (NP (DT an) (JJ important) (NN arbitrator))
                (PP (IN of)
                  (NP
                    (NP (DT the) (NN upregulation))
                    (PP (IN of)
                      (NP
                        (NP (NN IL-17))
                        (PP (IN in)
                          (NP (NNP RA))))))))
              (, ,)
              (PP (IN on)
                (S
                  (NP
                    (NP (DT the) (NN basis))
                    (PP (IN of)
                      (NP (PRP$ our) (NNS experiments))))
                  (VP (VBG showing)
                    (NP
                      (NP (JJ simultaneous) (NNS blocking))
                      (PP (IN of)
                        (NP
                          (NP (JJ NF-κB) (JJ binding) (NN activity))
                          (PP (IN in)
                            (NP (DT the) (NN IL-17) (NN promoter))))))
                    (PP (IN by)
                      (NP (NNP PDTC)
                        (CC and)
                        (NNP LY294002)))))))))))
    (. .)))

(ROOT
  (S
    (PP (VBG Considering)
      (NP
        (NP (PRP$ its) (JJ proinflammatory) (NNS activities))
        (CC and)
        (NP
          (NP (JJ successful) (NN induction))
          (PP (IN of)
            (NP
              (ADJP (JJ anti-IL-17)
                (PP (IN for)
                  (S
                    (VP (VBG ameliorating)
                      (NP (NN arthritis))
                      (PP (IN in)
                        (NP (NN animal) (NNS models)))))))
              (NNP -LSB-) (NNP 2,6,34-36) (NNP -RSB-))))))
    (, ,)
    (S
      (VP (VBG understanding)
        (NP
          (NP (DT the) (NN IL-17))
          (VP (VBG signaling)
            (ADVP (RB pathway))))))
    (VP (VBZ is)
      (NP
        (NP (DT an) (JJ important) (NN element))
        (PP (IN of)
          (S
            (VP (VBG developing)
              (NP (JJ new) (JJ targeted) (NNS therapies))
              (PP (IN in)
                (NP (NNP RA))))))))
    (. .)))

(ROOT
  (NP
    (NP
      (NP (NNS Conclusions))
      (SBAR
        (S
          (NP (PRP We))
          (VP (VBP have)
            (VP (VBN detected)
              (NP
                (NP (DT a)
                  (ADJP (RBR more) (JJ pronounced))
                  (NN production))
                (PP (IN of)
                  (NP (NN IL-17))))
              (PP (IN from)
                (NP
                  (NP (NNP RA) (NNP PBMC))
                  (PP (IN in)
                    (NP (NN response)))))
              (PP (TO to)
                (NP (NN IL-15)
                  (CC and)
                  (NN MCP-1))))))))
    (CONJP (RB as) (RB well) (IN as))
    (NP
      (NP (NN stimulation))
      (PP (IN by)
        (NP (JJ anti-CD3) (JJ /) (NN anti-CD28))))
    (. .)))

(ROOT
  (S
    (NP (PRP We))
    (VP (VBP have)
      (ADVP (RB also))
      (VP (VBN shown)
        (SBAR (IN that)
          (S
            (NP
              (NP (NN upregulation))
              (PP (IN of)
                (NP
                  (NP (NN IL-17))
                  (PP (IN by)
                    (NP
                      (NP (VBN activated) (NN T) (NNS cells))
                      (PP (IN in)
                        (NP
                          (NP (NNS patients))
                          (PP (IN with)
                            (NP (NNP RA))))))))))
            (VP (MD could)
              (VP (VB be)
                (NP
                  (NP (DT the) (NN result))
                  (PP (IN of)
                    (NP
                      (NP (NN activation))
                      (PP (IN via)
                        (NP
                          (NP (DT the) (JJ PI3K/Akt) (NN pathway))
                          (PP (IN with)
                            (NP (JJ resultant) (JJ NF-κB) (NN activation))))))))))))))
    (. .)))

(ROOT
  (S
    (NP (PRP$ Our) (NNS data))
    (VP
      (VP (VB provide)
        (NP (NNS insights))
        (PP (IN into)
          (NP
            (NP (JJ cellular) (NNS mechanisms))
            (PP (IN of)
              (NP
                (NP (DT the) (NN regulation))
                (PP (IN of)
                  (NP
                    (NP (NN IL-17) (NN production))
                    (PP (IN in)
                      (NP (NNP RA))))))))))
      (, ,)
      (CC and)
      (VP (VB highlight)
        (NP
          (NP (DT the) (NN role))
          (PP (IN of)
            (NP
              (NP (NNP T) (NNS cells))
              (, ,)
              (SBAR
                (WHNP (WDT which))
                (S
                  (VP (VBZ has)
                    (NP
                      (NP (NN hitherto))
                      (VP (VBN been)
                        (VP (VBN neglected)
                          (PP (IN in)
                            (NP (NNP RA) (NNS pathogenesis))))))))))))))
    (. .)))

(ROOT
  (S
    (ADVP (RB Together)
      (PP (IN with)
        (NP
          (NP (JJ recent) (NNS data))
          (PP (IN on)
            (NP
              (NP (DT the) (JJ successful) (NN introduction))
              (PP (IN of)
                (NP
                  (NP (JJ anti-IL-17))
                  (PP (IN in)
                    (NP (NNP RA))))))))))
    (, ,)
    (NP (PRP$ our) (NNS results))
    (VP (VBP have)
      (VP (VBN added)
        (NP
          (NP (NN information))
          (PP (IN for)
            (NP
              (NP (DT the) (JJ future) (JJ molecular) (NN targeting))
              (PP (IN of)
                (NP (JJ new) (JJ therapeutic) (NNS applications))))))
        (PP (IN in)
          (NP (NNP RA)))))
    (. .)))

(ROOT
  (NP
    (NP
      (NP (NNP Abbreviations) (NNP AP-1))
      (, ,)
      (NP (NN activator) (NN protein-1)))
    (: ;)
    (NP
      (NP
        (NP (NNP BSA))
        (SBAR
          (S
            (VP (SYM =)
              (NP (JJ bovine) (NN serum) (NN albumin))))))
      (: ;)
      (NP
        (NP (NNP EMSA))
        (SBAR
          (S
            (VP (SYM =)
              (NP (JJ electrophoretic) (JJ mobility-shift) (NN assay))))))
      (: ;)
      (NP
        (NP (NNP GAPDH))
        (SBAR
          (S
            (VP (SYM =)
              (NP (JJ glyceraldehyde-3-phosphate) (NN dehydrogenase))))))
      (: ;)
      (NP
        (NP (NNP IL))
        (SBAR
          (S
            (VP (SYM =)
              (NP (NN interleukin))))))
      (: ;)
      (NP
        (NP (NNP MAPK))
        (SBAR
          (S
            (VP (SYM =)
              (NP (JJ mitogen-activated) (NN protein) (NN kinase))))))
      (: ;)
      (NP
        (NP (NN MCP-1))
        (SBAR
          (S
            (VP (SYM =)
              (NP (JJ monocyte) (NN chemoattractant) (NN protein-1))))))
      (: ;)
      (NP
        (NP (NNP MIP))
        (SBAR
          (S
            (VP (SYM =)
              (NP (JJ macrophage) (JJ inflammatory) (NN protein))))))
      (: ;)
      (NP
        (NP (NNP NF-κB))
        (SBAR
          (S
            (VP (SYM =)
              (NP (JJ nuclear) (NN factor) (NN κB))))))
      (: ;)
      (NP
        (NP (NNP OA))
        (SBAR
          (S
            (VP (SYM =)
              (NP (NNS osteoarthritis))))))
      (: ;)
      (NP
        (NP (NNP PBMC))
        (SBAR
          (S
            (VP (SYM =)
              (NP (JJ peripheral) (NN blood) (NN mononuclear) (NNS cells))))))
      (: ;)
      (NP
        (NP (NNP PDTC))
        (SBAR
          (S
            (VP (SYM =)
              (NP (JJ pyrrolidine) (NN dithiocarbamate))))))
      (: ;)
      (NP
        (NP (NNP PHA))
        (SBAR
          (S
            (VP (SYM =)
              (NP (NN phytohemagglutinin))))))
      (: ;)
      (NP
        (NP (NNP PI3K) (NNP =))
        (ADJP (JJ phosphoinositide) (JJ 3-kinase)))
      (: ;)
      (NP
        (NP (NNP RA))
        (SBAR
          (S
            (VP (SYM =)
              (NP (JJ rheumatoid) (NN arthritis))))))
      (: ;)
      (NP
        (NP (NNP TGF))
        (SBAR
          (S
            (VP (SYM =)
              (NP (JJ transforming) (NN growth) (NN factor))))))
      (: ;)
      (NP
        (NP (NNP Th))
        (SBAR
          (S
            (VP (SYM =)
              (NP (NNP T) (NN helper))))))
      (: ;)
      (NP
        (NP (NNP TNF))
        (SBAR
          (S
            (VP (SYM =)
              (NP (NN tumor) (NNS necrosis) (NN factor)))))))
    (. .)))

(ROOT
  (S
    (NP
      (NP
        (NP (JJ Competing) (NNS interests))
        (NP (DT The) (NN author)))
      (PRN (-LRB- -LRB-) (PRP s) (-RRB- -RRB-)))
    (VP (VBP declare)
      (SBAR (IN that)
        (S
          (NP (PRP they))
          (VP (VBP have)
            (NP (DT no) (VBG competing) (NNS interests))))))
    (. .)))

(ROOT
  (S
    (NP
      (NP (NNP Authors) (POS '))
      (NNS contributions) (NN KWK))
    (VP
      (VP (VBD performed)
        (NP (DT the) (JJ cellular) (JJ immune) (NN response) (NNS studies)))
      (CC and)
      (VP (VBD participated)
        (PP (IN in)
          (NP (DT the) (NNS immunoassays)))))
    (. .)))

(ROOT
  (S
    (NP (NNP MLC))
    (VP
      (VP (VBD participated)
        (PP (IN in)
          (NP
            (NP (DT the) (NN design))
            (PP (IN of)
              (NP (DT the) (NN study))))))
      (CC and)
      (VP (VBD performed)
        (NP (DT the) (JJ statistical) (NN analysis))))
    (. .)))

(ROOT
  (S
    (NP (NNP MKP))
    (VP (VBD participated)
      (PP (IN in)
        (NP
          (NP (DT the) (NN isolation))
          (PP (IN of)
            (NP (DT the) (NNS cells))))))
    (. .)))

(ROOT
  (S
    (NP (NNP CHY))
    (VP (VBD drafted)
      (NP (DT the) (NN manuscript)))
    (. .)))

(ROOT
  (S
    (NP (NNP SHP))
    (VP (VBD participated)
      (PP
        (PP (IN in)
          (NP (DT the) (JJ molecular) (NN biology)))
        (CC and)
        (PP (IN in)
          (NP (DT the) (NNP PCR)))))
    (. .)))

(ROOT
  (S
    (NP (NNP SHL))
    (VP
      (VP (VBD conceived)
        (NP (DT the) (NN study)))
      (, ,)
      (VP (VBD participated)
        (PP (IN in)
          (NP (PRP$ its) (NN design)
            (CC and)
            (NN coordination))))
      (CC and)
      (VP (VBD helped)
        (S
          (VP (TO to)
            (VP (VB draft)
              (NP (DT the) (NN manuscript)))))))
    (. .)))

(ROOT
  (S
    (NP (NNP HYK))
    (VP (VBD helped)
      (S
        (VP (TO to)
          (VP (VB draft)
            (NP (DT the) (NN manuscript))))))
    (. .)))

(ROOT
  (S
    (NP (DT All) (NNS authors))
    (VP
      (VP (VBD read))
      (CC and)
      (VP (VBD approved)
        (NP (DT the) (JJ final) (NN manuscript))))
    (. .)))

(ROOT
  (S
    (NP (NNP Figure)
      (CC and)
      (NNP Table))
    (VP
      (VP (VBZ captions)
        (NP (NNP Figure) (CD 1)))
      (: :)
      (NP
        (NP (NNP Levels))
        (PP (IN of)
          (NP (NN interleukin)))
        (PRN (-LRB- -LRB-)
          (NP (NNP IL))
          (-RRB- -RRB-))
        (NP
          (NP (CD -17) (NN production))
          (PP (IN in)
            (NP (JJ peripheral) (NN blood) (NN mononuclear) (NNS cells)))
          (PP (IN from)
            (NP
              (NP (NNS patients))
              (PP (IN with)
                (NP
                  (NP (JJ rheumatoid) (NN arthritis))
                  (PRN (-LRB- -LRB-)
                    (NP
                      (NP (NNP RA))
                      (: ;)
                      (NP
                        (NP (NN n))
                        (SBAR
                          (S
                            (VP (SYM =)
                              (NP (CD 24)))))))
                    (-RRB- -RRB-))))))
          (, ,)
          (NP
            (NP
              (NP (NNS patients))
              (PP (IN with)
                (NP
                  (NP (NNS osteoarthritis))
                  (PRN (-LRB- -LRB-)
                    (NP (NNP OA))
                    (-RRB- -RRB-)))))
            (PRN (-LRB- -LRB-)
              (VP (VBN n)
                (S
                  (VP (SYM =)
                    (NP (CD 14)))))
              (-RRB- -RRB-)))
          (CC and)
          (NP
            (NP (JJ normal) (NNS individuals))
            (PRN (-LRB- -LRB-)
              (VP (VBN n)
                (S
                  (VP (SYM =)
                    (NP (CD 14)))))
              (-RRB- -RRB-))))))
    (. .)))

(ROOT
  (S
    (NP (DT Each) (JJ peripheral) (NN blood) (NN mononuclear) (NN cell))
    (VP (VBD was)
      (VP (VBN stimulated)
        (PP (IN for)
          (NP (CD 24) (NNS hours)))
        (PP (IN with)
          (CC or)
          (IN without)
          (NP
            (NP (NN phytohemagglutinin))
            (PRN (-LRB- -LRB-)
              (NP
                (NP (NNP PHA))
                (: ;)
                (NP (CD 5) (NN μg) (NN /) (NN ml)))
              (-RRB- -RRB-))))))
    (. .)))

(ROOT
  (S
    (NP (NNP IL-17))
    (VP (VBD was)
      (VP (VBN measured)
        (PP (IN in)
          (NP (NN culture) (NNS supernatants)))
        (PP (IN by)
          (NP (NN sandwich) (JJ enzyme-linked) (JJ immunosorbent) (NN assay)))))
    (. .)))

(ROOT
  (S
    (NP (NNP Data))
    (VP (VBP are)
      (VP (VBN expressed)
        (PP (IN as)
          (NP
            (NP (NNS means))
            (CC and)
            (NP (NNP SEM))))))
    (. .)))

(ROOT
  (S
    (NP
      (NP (CD One) (NN representative) (NN result))
      (PP (IN of)
        (NP (CD five) (JJ independent) (NNS experiments))))
    (VP (VBZ is)
      (VP (VBN shown)))
    (. .)))

(ROOT
  (S
    (NP
      (NP (NNP Student) (POS 's))
      (NN t-test))
    (VP (VBD was)
      (VP (VBN used)
        (S
          (VP (TO to)
            (VP (VB compare)
              (NP (DT each) (NN group)))))))
    (. .)))

(ROOT
  (NP
    (NP (NNP *) (, ,) (NNP P) (NNP <) (CD 0.05))
    (: ;)
    (NP (NNP **) (, ,) (NNP P) (NNP <) (CD 0.001))
    (. .)))

(ROOT
  (NP
    (NP (NNP Figure) (CD 2))
    (: :)
    (NP
      (NP (NN Production))
      (PP (IN of)
        (NP
          (NP (NN interleukin))
          (PRN (-LRB- -LRB-)
            (NP (NNP IL))
            (-RRB- -RRB-))
          (VP (VBN -17)
            (PP (IN by)
              (NP
                (NP (JJ peripheral) (NN blood) (NN mononuclear) (NNS cells))
                (PRN (-LRB- -LRB-)
                  (NP (NNP PBMC))
                  (-RRB- -RRB-))))
            (PP (IN from)
              (NP
                (NP (NNS patients))
                (PP (IN with)
                  (NP
                    (NP (JJ rheumatoid) (NN arthritis))
                    (PRN (-LRB- -LRB-)
                      (NP (NNP RA))
                      (-RRB- -RRB-))))))))))
    (. .)))

(ROOT
  (NP
    (LST (-LRB- -LRB-) (DT a) (-RRB- -RRB-))
    (NP (NN Production))
    (PP (IN of)
      (NP
        (NP (NN IL-17))
        (PP (IN by)
          (NP (JJ cytokine) (NN induction)))))
    (. .)))

(ROOT
  (S
    (NP
      (NP (NNP PBMC))
      (PP (IN from)
        (NP
          (NP (NNS patients))
          (PP (IN with)
            (NP (NNP RA))))))
    (VP (VBD were)
      (VP (VBN stimulated)
        (PP (IN for)
          (NP
            (NP (CD 24) (NNS hours))
            (PP (IN with)
              (NP
                (NP
                  (NP (NN IL-15))
                  (PRN (-LRB- -LRB-)
                    (NP (CD 10) (NN ng/ml))
                    (-RRB- -RRB-)))
                (, ,)
                (NP
                  (NP (NNS IL-1β))
                  (PRN (-LRB- -LRB-)
                    (NP (CD 10) (NN ng/ml))
                    (-RRB- -RRB-)))
                (, ,)
                (NP
                  (NP (NN tumor) (NNS necrosis) (NNS factor-α))
                  (PRN (-LRB- -LRB-)
                    (NP
                      (NP (NNP TNF-α))
                      (: ;)
                      (NP (CD 10) (NN ng/ml)))
                    (-RRB- -RRB-)))
                (, ,)
                (NP
                  (NP (NN IL-18))
                  (PRN (-LRB- -LRB-)
                    (NP (CD 10) (NN ng/ml))
                    (-RRB- -RRB-)))
                (CC and)
                (NP
                  (NP (JJ transforming) (NN growth) (NNS factor-β))
                  (PRN (-LRB- -LRB-)
                    (NP
                      (NP (NNP TGF-β))
                      (: ;)
                      (NP (CD 10) (NN ng/ml)))
                    (-RRB- -RRB-)))))))))
    (. .)))

(ROOT
  (S
    (NP
      (NP (NNS Levels))
      (PP (IN of)
        (NP (NN IL-17))))
    (VP (VBD were)
      (VP (VBN measured)
        (PP (IN in)
          (NP (NN culture) (NNS supernatants)))
        (PP (IN by)
          (NP (JJ enzyme-linked) (NN immunosorbent) (NN assay)))))
    (. .)))

(ROOT
  (S
    (NP (DT Each) (NN value))
    (VP (VBZ represents)
      (NP
        (NP (DT the) (NN mean)
          (CC and)
          (NN SEM))
        (PP (IN of)
          (NP (CD three) (JJ independent) (NNS experiments)))))
    (. .)))

(ROOT
  (NP
    (LST (-LRB- -LRB-) (NN b) (-RRB- -RRB-))
    (NP (NN Production))
    (PP (IN of)
      (NP
        (NP (NN IL-17))
        (PP (IN by)
          (NP (JJ chemokine) (NN induction)))))
    (. .)))

(ROOT
  (S
    (NP (NNP PBMC))
    (VP (VBD were)
      (VP (VBN cultured)
        (PP (IN in)
          (NP
            (NP (DT the) (NN presence))
            (PP (IN of)
              (NP
                (NP
                  (NP (JJ monocyte) (NN chemoattractant) (NN protein-1))
                  (PRN (-LRB- -LRB-)
                    (NP
                      (NP (NN MCP-1))
                      (: ;)
                      (NP (CD 10) (NN ng/ml)))
                    (-RRB- -RRB-)))
                (, ,)
                (NP
                  (NP
                    (ADJP (JJ macrophage) (JJ inflammatory))
                    (JJ protein-1α))
                  (PRN (-LRB- -LRB-)
                    (NP
                      (NP (NNS MIP-1α))
                      (: ;)
                      (NP (CD 10) (NN ng/ml)))
                    (-RRB- -RRB-)))
                (, ,)
                (NP
                  (NP (NNS MIP-1β))
                  (PRN (-LRB- -LRB-)
                    (NP (CD 10) (NN ng/ml))
                    (-RRB- -RRB-)))
                (, ,)
                (NP
                  (NP (NN IL-6))
                  (PRN (-LRB- -LRB-)
                    (NP (CD 10) (NN ng/ml))
                    (-RRB- -RRB-)))
                (CC and)
                (NP
                  (NP (NN IL-8))
                  (PRN (-LRB- -LRB-)
                    (NP (CD 10) (NN ng/ml))
                    (-RRB- -RRB-)))))))))
    (. .)))

(ROOT
  (S
    (ADVP (RB *))
    (, ,)
    (NP (NNP P))
    (VP (VBZ <)
      (NP (CD 0.05)))
    (. .)))

(ROOT
  (NP
    (NP (NNP Figure) (CD 3))
    (: :)
    (NP
      (NP
        (NP (NNPS Effects))
        (PP (IN of)
          (NP (NN protein) (NN kinase) (NNS inhibitors))))
      (CC and)
      (NP
        (NP (JJ anti-rheumatic) (NN drug))
        (PP (IN on)
          (NP (JJ anti-CD3) (NNS triggered) (NN interleukin)
            (PRN (-LRB- -LRB-)
              (NP (NNP IL))
              (-RRB- -RRB-))
            (JJ -17) (NN production)))
        (PP (IN by)
          (NP
            (NP
              (NP (JJ peripheral) (NN blood) (NN mononuclear) (NNS cells))
              (PRN (-LRB- -LRB-)
                (NP (NNP PBMC))
                (-RRB- -RRB-)))
            (PP (IN from)
              (NP
                (NP (NNS patients))
                (PP (IN with)
                  (NP (JJ rheumatoid) (NN arthritis)))))))))
    (. .)))

(ROOT
  (S
    (NP (NNP PBMC))
    (VP (VBD pretreated)
      (PP (IN for)
        (NP
          (NP (CD 1) (NN hour))
          (PP (IN with)
            (NP
              (NP
                (NP
                  (NP (JJ pyrrolidine) (NN dithiocarbamate))
                  (PRN (-LRB- -LRB-)
                    (NP
                      (NP (NNP PDTC))
                      (: ;)
                      (NP (CD 300) (NN μM)))
                    (-RRB- -RRB-)))
                (, ,)
                (NP
                  (NP (NN curcumin))
                  (PRN (-LRB- -LRB-)
                    (NP
                      (QP (CD 10) (CD μM)))
                    (-RRB- -RRB-)))
                (, ,)
                (NP
                  (NP (NNP LY294002))
                  (PRN (-LRB- -LRB-)
                    (NP
                      (QP (CD 20) (CD μM)))
                    (-RRB- -RRB-)))
                (, ,)
                (NP
                  (NP (NN wortmannin))
                  (PRN (-LRB- -LRB-)
                    (NP
                      (QP (CD 200) (CD nM)))
                    (-RRB- -RRB-)))
                (, ,)
                (NP
                  (NP (NNP Cyclosporin) (NNP A))
                  (PRN (-LRB- -LRB-)
                    (NP (CD 500) (NN ng/ml))
                    (-RRB- -RRB-)))
                (, ,)
                (NP
                  (NP (NN dexamethasone))
                  (PRN (-LRB- -LRB-)
                    (NP
                      (NP (NNP DEX))
                      (: ;)
                      (NP (CD 100) (NN nM)))
                    (-RRB- -RRB-)))
                (, ,)
                (NP
                  (NP (NNP FK506))
                  (PRN (-LRB- -LRB-)
                    (NP (CD 100) (NN ng/ml))
                    (-RRB- -RRB-)))
                (, ,)
                (NP
                  (NP (NN rapamycin))
                  (PRN (-LRB- -LRB-)
                    (NP (CD 10) (NN ng/ml))
                    (-RRB- -RRB-)))
                (, ,)
                (NP
                  (NP (NNP SB203580))
                  (PRN (-LRB- -LRB-)
                    (NP
                      (QP (CD 10) (CD nM)))
                    (-RRB- -RRB-))))
              (CC or)
              (NP
                (NP
                  (NP (NNP PD98059))
                  (PRN (-LRB- -LRB-)
                    (NP
                      (QP (CD 20) (CD μM)))
                    (-RRB- -RRB-)))
                (PP (IN in)
                  (NP (NN combination))))))))
      (PP (IN with)
        (NP (JJ anti-CD3) (NN antibody)))
      (PRN (-LRB- -LRB-)
        (NP
          (QP (CD 5) (CD μg))
          (NN /) (NN ml))
        (-RRB- -RRB-)))
    (. .)))

(ROOT
  (S
    (NP (NNP Culture) (NNP supernatant))
    (VP (VBD was)
      (VP (VBN assayed)
        (PP (IN for)
          (NP (NN IL-17)))
        (SBAR (IN as)
          (S
            (VP (VBN described)
              (PP (IN in)
                (NP (DT the) (NNS Materials)
                  (CC and)
                  (NNS methods) (NN section))))))))
    (. .)))

(ROOT
  (S
    (NP (DT Each) (NN value))
    (VP (VBZ represents)
      (NP
        (NP (DT the) (NN mean)
          (CC and)
          (NN SEM))
        (PP (IN of)
          (NP (CD three) (JJ independent) (NNS experiments)))))
    (. .)))

(ROOT
  (NP
    (NP (NNP *) (, ,) (NNP P) (NNP <) (CD 0.05))
    (: ;)
    (NP (NNP **) (, ,) (NNP P) (NNP <) (CD 0.005))
    (. .)))

(ROOT
  (NP
    (NP (NNP Figure) (CD 4))
    (: :)
    (NP
      (NP
        (NP (JJ Dose-dependent) (NNS effects))
        (PP (IN of)
          (NP (NNP LY294002))))
      (CC or)
      (NP
        (NP
          (NP (JJ pyrrolidine) (NN dithiocarbamate))
          (PRN (-LRB- -LRB-)
            (NP (NNP PDTC))
            (-RRB- -RRB-)))
        (PP (IN in)
          (NP
            (NP
              (NP (JJ peripheral) (NN blood) (NN mononuclear) (NNS cells))
              (PRN (-LRB- -LRB-)
                (NP (NNP PBMC))
                (-RRB- -RRB-)))
            (PP (IN from)
              (NP
                (NP (NNS patients))
                (PP (IN with)
                  (NP
                    (NP (JJ rheumatoid) (NN arthritis))
                    (PRN (-LRB- -LRB-)
                      (NP (NNP RA))
                      (-RRB- -RRB-))))))))))
    (. .)))

(ROOT
  (S
    (NP
      (NP
        (LST (-LRB- -LRB-) (DT a) (-RRB- -RRB-))
        (NP (NN Effect))
        (PP (IN of)
          (NP
            (NP (NNS inhibitors))
            (PP (IN on)
              (NP (NN interleukin))))))
      (PRN (-LRB- -LRB-)
        (NP (NNP IL))
        (-RRB- -RRB-)))
    (VP (VBD -17)
      (NP (NN release))
      (PP (IN by)
        (NP (JJ anti-CD3-stimulated) (NN PBMC)))
      (PP (IN from)
        (NP
          (NP (NNS patients))
          (PP (IN with)
            (NP (NNP RA))))))
    (. .)))

(ROOT
  (NP
    (LST (-LRB- -LRB-) (NN b) (-RRB- -RRB-))
    (NP (NNPS Effects))
    (PP (IN of)
      (NP
        (NP (NNP LY294002)
          (CC or)
          (NNP PDTC))
        (PP (IN on)
          (NP (NNP PBMC) (NN viability)))))
    (. .)))

(ROOT
  (S
    (NP (NNP PBMC))
    (VP (VBD were)
      (VP (VBN cultured)
        (PP (IN at)
          (NP
            (NP (DT a) (NN concentration))
            (PP (IN of)
              (NP
                (NP (CD 2) (JJ ×) (CD 105) (NNS cells))
                (PP (IN per)
                  (NP
                    (NP
                      (ADVP (RB well)
                        (PP (IN with)
                          (ADJP (JJ medium) (, ,) (JJ anti-CD3) (, ,) (JJ anti-CD3)
                            (CC and)
                            (JJ LY294002)))))
                    (CC or)
                    (NP (NNP PDTC))))))))
        (PP (IN under)
          (NP
            (NP (DT the) (NNS conditions))
            (VP (VBN described)
              (PP (IN in)
                (NP (DT the) (NNS Materials)
                  (CC and)
                  (NNS methods) (NN section))))))))
    (. .)))

(ROOT
  (S
    (PP (IN After)
      (NP
        (NP (CD 24) (NNS hours))
        (PP (IN of)
          (NP (NN treatment)))))
    (, ,)
    (NP (NN cell) (NN viability))
    (VP (VBD was)
      (VP
        (VP (VBN assessed)
          (PP (IN by)
            (NP (DT the) (JJ trypan) (JJ blue) (NN dye) (NN exclusion) (NN method))))
        (CC and)
        (VP (VBN expressed)
          (PP (IN as)
            (NP
              (NP (DT a) (NN percentage))
              (PP (IN with)
                (NP
                  (NP (DT the) (NN formula)
                    (QP (CD 100) (CD ×)))
                  (PRN (-LRB- -LRB-)
                    (NP
                      (NP (NN number))
                      (PP (IN of)
                        (NP
                          (NP (JJ viable) (NN cells/number))
                          (PP (IN of)
                            (NP
                              (ADJP (DT both) (JJ viable)
                                (CC and)
                                (JJ dead))
                              (NNS cells))))))
                    (-RRB- -RRB-)))))))))
    (. .)))

(ROOT
  (NP
    (NP (NNP Figure) (CD 5))
    (: :)
    (NP
      (NP
        (NP (NNPS Effects))
        (PP (IN of)
          (NP (NNP LY294002))))
      (CC or)
      (NP
        (NP
          (NP (JJ pyrrolidine) (NN dithiocarbamate))
          (PRN (-LRB- -LRB-)
            (NP (NNP PDTC))
            (-RRB- -RRB-)))
        (PP (IN on)
          (NP
            (NP (JJ anti-CD3) (JJ antibody-triggered) (NN interleukin))
            (PRN (-LRB- -LRB-)
              (NP (NNP IL))
              (-RRB- -RRB-))))))
    (X
      (NP
        (NP (CD -17) (NN mRNA) (NN expression))
        (PP (IN by)
          (NP (JJ peripheral) (NN blood))))
      (NP
        (NP
          (NP (NN mononuclear) (NNS cells))
          (PRN (-LRB- -LRB-)
            (NP (NNP PBMC))
            (-RRB- -RRB-)))
        (PP (IN from)
          (NP
            (NP (NNS patients))
            (PP (IN with)
              (NP (JJ rheumatoid) (NN arthritis))))))
      (. .))))

(ROOT
  (S
    (S
      (NP (NNP PBMC))
      (VP (VBD were)
        (VP (VBN cultured)
          (PP (IN with)
            (NP
              (NP
                (NP
                  (NP
                    (NP (NN medium) (RB only))
                    (PRN (-LRB- -LRB-)
                      (NP
                        (QP (CD lane) (CD 1)))
                      (-RRB- -RRB-)))
                  (, ,)
                  (NP
                    (NP (JJ anti-CD3) (NN antibody))
                    (PRN (-LRB- -LRB-)
                      (NP (CD 1) (NNS μg))
                      (: /)
                      (NP
                        (NP (NN ml))
                        (: ;)
                        (NP (NN lane) (CD 2)))
                      (-RRB- -RRB-)))
                  (, ,)
                  (NP
                    (NP (JJ anti-CD3) (NN antibody))
                    (PRN (-LRB- -LRB-)
                      (NP (CD 10) (NNS μg))
                      (: /)
                      (NP
                        (NP (NN ml))
                        (: ;)
                        (NP (NN lane) (CD 3)))
                      (-RRB- -RRB-)))
                  (, ,)
                  (NP
                    (NP (JJ anti-CD3) (NN antibody))
                    (PRN (-LRB- -LRB-)
                      (NP
                        (QP (CD 10) (CD μg))
                        (NN /) (NN ml))
                      (-RRB- -RRB-))))
                (CC plus)
                (NP
                  (NP (NNP LY294002))
                  (PRN (-LRB- -LRB-)
                    (NP
                      (NP (CD 20) (NN μM))
                      (: ;)
                      (NP (NN lane) (CD 4)))
                    (-RRB- -RRB-))))
              (CC or)
              (NP
                (NP
                  (NP (JJ anti-CD3) (NN antibody))
                  (PRN (-LRB- -LRB-)
                    (NP
                      (QP (CD 10) (CD μg))
                      (NN /) (NN ml))
                    (-RRB- -RRB-)))
                (PP (CC plus)
                  (NP
                    (NP
                      (NP (NNP PDTC))
                      (PRN (-LRB- -LRB-)
                        (NP
                          (NP (CD 300) (NN μM))
                          (: ;)
                          (NP (NN lane) (CD 5)))
                        (-RRB- -RRB-)))
                    (PP (IN for)
                      (NP (CD 12) (NNS hours)))))))))))
    (: ;)
    (S
      (NP (NN lane) (CD 6))
      (VP (VBZ shows)
        (NP (DT a) (JJ negative) (NN control))))
    (. .)))

(ROOT
  (S
    (S
      (NP
        (NP (NNP Total) (NNP RNA))
        (PRN (-LRB- -LRB-)
          (NP
            (QP (CD 2) (CD μg)))
          (-RRB- -RRB-)))
      (VP (VBD was)
        (VP (VBN used)
          (PP (IN for)
            (NP (NN cDNA) (NN synthesis)))
          (PP (IN in)
            (NP
              (NP (DT a) (NN volume))
              (PP (IN of)
                (NP (CD 20) (NN μl))))))))
    (: ;)
    (S
      (NP
        (NP (CD 1) (NN μl))
        (PP (IN of)
          (NP (DT the) (JJ synthesized) (NN cDNA))))
      (VP (VBD was)
        (VP (VBN used)
          (PP (IN for)
            (NP
              (NP (JJ reverse) (NN transcription))
              (: --)
              (NP
                (NP (NN polymerase) (NN chain) (NN reaction))
                (SBAR (IN as)
                  (S
                    (VP (VBD described))))))))))
    (. .)))

(ROOT
  (S
    (NP
      (NP (NNP PCR) (NN reaction) (NN product))
      (PRN (-LRB- -LRB-)
        (NP
          (QP (CD 25) (CD μl)))
        (-RRB- -RRB-)))
    (VP (VBD was)
      (VP (VBN separated)
        (PP (IN on)
          (NP
            (NP (DT an) (JJ agarose) (NN gel))
            (VP (VBG containing)
              (NP (NN ethidium) (NN bromide)))))))
    (. .)))

(ROOT
  (S
    (NP
      (NP (DT The) (JJ relative) (NNS intensities))
      (PP (IN of)
        (NP (DT the) (NNS bands))))
    (VP (VBD were)
      (VP (VBN revealed)
        (PP (IN under)
          (NP (NNP UV) (NN radiation)))))
    (. .)))

(ROOT
  (NP
    (NP (NNP Figure) (CD 6))
    (: :)
    (NP
      (NP (NNP Activation))
      (PP (IN of)
        (NP
          (NP
            (NP (JJ phosphorylated) (NN Akt))
            (PP (IN after)
              (NP
                (NP (NN interleukin))
                (PRN (-LRB- -LRB-)
                  (NP (NNP IL))
                  (-RRB- -RRB-)))))
          (NP
            (NP (CD -17) (NN induction))
            (PP (IN by)
              (NP (JJ anti-CD3) (NN antibody))))
          (, ,)
          (CC and)
          (NP
            (NP (PRP$ its) (NN inhibition))
            (PP (IN by)
              (NP (NNP LY294002)))))))
    (. .)))

(ROOT
  (S
    (NP (JJ Peripheral) (NN blood) (NN mononuclear) (NNS cells))
    (VP (VBD were)
      (VP (VBN cultured)
        (PP (IN with)
          (NP
            (NP
              (NP
                (NP
                  (NP (NN medium) (RB only))
                  (PRN (-LRB- -LRB-)
                    (NP
                      (QP (CD lane) (CD 1)))
                    (-RRB- -RRB-)))
                (, ,)
                (NP
                  (NP (JJ anti-CD3) (NN antibody))
                  (PRN (-LRB- -LRB-)
                    (NP (CD 10) (NNS μg))
                    (: /)
                    (NP
                      (NP (NN ml))
                      (: ;)
                      (NP (NN lane) (CD 2)))
                    (-RRB- -RRB-)))
                (CC or)
                (NP
                  (NP (JJ anti-CD3) (NN antibody))
                  (PRN (-LRB- -LRB-)
                    (NP
                      (QP (CD 10) (CD μg))
                      (NN /) (NN ml))
                    (-RRB- -RRB-))))
              (CC plus)
              (NP
                (NP
                  (NP (NNP LY294002))
                  (PRN (-LRB- -LRB-)
                    (NP
                      (NP (CD 20) (NN μM))
                      (: ;)
                      (NP (NN lane) (CD 3)))
                    (-RRB- -RRB-)))
                (PP (IN for)
                  (NP (CD 10)))))
            (: --)
            (NP (CD 120) (NN min))))))
    (. .)))

(ROOT
  (S
    (NP (JJ Cell) (NNS lysates))
    (VP (VBD were)
      (VP (VBN analyzed)
        (PP (IN for)
          (NP (NNP Akt) (NN activation)))
        (PP (IN by)
          (S
            (NP
              (NP (JJ western) (NN blot) (NN analysis))
              (PP (IN of)
                (NP
                  (NP
                    (ADJP (JJ total)
                      (CC and)
                      (JJ Ser473-phosphorylated))
                    (NN Akt))
                  (PRN (-LRB- -LRB-)
                    (NP (NNP P-Akt))
                    (-RRB- -RRB-)))))
            (VP (VBG using)
              (NP (JJ specific) (NNS antibodies)))))))
    (. .)))

(ROOT
  (S
    (NP
      (NP (NNS Levels))
      (PP (IN of)
        (NP (JJ phosphorylated) (NN Akt))))
    (VP (VBD were)
      (VP (VBN compared)
        (PP (IN at)
          (NP (DT each) (NN time) (NN point)))
        (, ,)
        (PP (IN after)
          (NP
            (NP
              (NP (NN normalization))
              (PP (TO to)
                (NP (NNP Akt))))
            (CC and)
            (NP
              (NP (NN β-actin))
              (PP (IN in)
                (NP (DT the) (JJ same) (NN sample))))))))
    (. .)))

(ROOT
  (S
    (NP
      (NP (DT A) (JJ representative) (NN example))
      (PP (IN of)
        (NP (CD three) (JJ separate) (NNS experiments))))
    (VP (VBZ is)
      (VP (VBN shown)))
    (. .)))

(ROOT
  (NP
    (NP (NNP Figure) (CD 7))
    (: :)
    (NP
      (NP (NNPS Effects))
      (PP (IN of)
        (NP
          (NP
            (NP (JJ anti-CD3))
            (PP (CC plus)
              (NP
                (NP
                  (ADJP (JJ anti-CD28)
                    (PP (IN on)
                      (NP (NNP NF-κB)
                        (ADJP (JJ complex)
                          (PP (IN in)
                            (NP
                              (NP (JJ nuclear) (NNS extracts))
                              (PP (IN of)
                                (NP
                                  (NP (JJ rheumatoid) (NN arthritis))
                                  (PRN (-LRB- -LRB-)
                                    (NP (NNP RA))
                                    (-RRB- -RRB-)))))))
                        (JJ peripheral) (NN blood) (NN mononuclear))))
                  (NNS cells))
                (PRN (-LRB- -LRB-)
                  (NP (NNP PBMC))
                  (-RRB- -RRB-)))))
          (CC and)
          (NP (JJ normal) (NN PBMC)))))
    (. .)))

(ROOT
  (S
    (LST (-LRB- -LRB-) (DT a) (-RRB- -RRB-))
    (VP (VB NF-κB)
      (NP (NN activity))
      (PP (IN in)
        (NP
          (NP
            (NP
              (NP
                (NP (DT the) (NN absence))
                (PRN (-LRB- -LRB-)
                  (NP
                    (QP (CD lane) (CD 1)))
                  (-RRB- -RRB-)))
              (CC or)
              (NP
                (NP
                  (NP (NN presence))
                  (PRN (-LRB- -LRB-)
                    (NP
                      (QP (CD lane) (CD 2)))
                    (-RRB- -RRB-)))
                (PP (IN of)
                  (NP (JJ anti-CD3) (JJ plus) (JJ anti-CD28) (NN antibody))))
              (: ;)
              (NP
                (NP (JJ supershift) (NN assay))
                (PP (IN of)
                  (NP
                    (NP (JJ NF-κB) (NN site))
                    (PP (IN with)
                      (NP
                        (NP (NNS antibodies))
                        (PP (IN against)
                          (NP (CD p65)))))))))
            (PRN (-LRB- -LRB-)
              (NP
                (QP (CD lane) (CD 3)))
              (-RRB- -RRB-)))
          (, ,)
          (NP
            (NP (NNS p50))
            (PRN (-LRB- -LRB-)
              (NP
                (QP (CD lane) (CD 4)))
              (-RRB- -RRB-)))
          (CC and)
          (NP
            (NP (NN c-Rel))
            (PRN (-LRB- -LRB-)
              (NP
                (QP (CD lane) (CD 5)))
              (-RRB- -RRB-))))))
    (. .)))

(ROOT
  (S
    (NP
      (NP (NNP PBMC))
      (PP (IN from)
        (NP
          (NP (NNS patients))
          (PP (IN with)
            (NP (NNP RA))))))
    (VP
      (VP (VBD were)
        (VP (VBN stimulated)
          (PP (IN with)
            (NP (JJ anti-CD3) (NN plus) (NNS anti-CD28)))))
      (CC and)
      (VP (VBD were)
        (VP (VBN used)
          (PP (IN for)
            (NP (DT the) (JJ supershift) (NN assay))))))
    (. .)))

(ROOT
  (S
    (LST (-LRB- -LRB-) (NN b) (-RRB- -RRB-))
    (VP (VB NF-κB)
      (NP
        (NP
          (NP (NN activity))
          (PP (IN in)
            (NP
              (NP (DT the) (NN absence))
              (PRN (-LRB- -LRB-)
                (NP
                  (QP (CD lane) (CD 1)))
                (-RRB- -RRB-))
              (CC or)
              (NP (NN presence))
              (PRN (-LRB- -LRB-)
                (NP
                  (QP (CD lane) (CD 2)))
                (-RRB- -RRB-))))
          (PP (IN of)
            (NP (JJ anti-CD3) (NN antibody))))
        (CC plus)
        (NP
          (NP (JJ anti-CD28))
          (PP (IN in)
            (NP (JJ normal) (NN PBMC))))))
    (. .)))

(ROOT
  (S
    (LST (-LRB- -LRB-) (NN c) (-RRB- -RRB-))
    (VP (VB NF-κB)
      (NP
        (NP (NN activity))
        (PP (IN in)
          (NP
            (NP (DT the) (NN absence))
            (PRN (-LRB- -LRB-)
              (NP
                (QP (CD lane) (CD 1)))
              (-RRB- -RRB-))
            (CC or)
            (NP (NN presence))
            (PRN (-LRB- -LRB-)
              (NP
                (QP (CD lane) (CD 2)))
              (-RRB- -RRB-))))
        (PP (IN of)
          (NP
            (NP (JJ anti-CD3) (, ,) (JJ anti-CD3) (NN plus) (NNS LY294002))
            (PRN (-LRB- -LRB-)
              (NP
                (QP (CD lane) (CD 3)))
              (-RRB- -RRB-))
            (CC or)
            (NP (JJ anti-CD3) (JJ plus) (NN pyrrolidine) (NN dithiocarbamate))
            (PRN (-LRB- -LRB-)
              (NP
                (NP (NNP PDTC))
                (: ;)
                (NP (NN lane) (CD 4)))
              (-RRB- -RRB-))))))
    (. .)))

(ROOT
  (S
    (NP (NNS Arrows))
    (VP (VBP denote)
      (NP
        (NP (DT a) (JJ labeled) (NN oligonucleotide) (NN band))
        (VP (VBN shifted)
          (PP (IN after)
            (NP (NNP NF-κB) (NNP binding))))))
    (. .)))

(ROOT
  (S
    (NP (DT The) (JJR lower) (NN panel))
    (VP (VBZ shows)
      (NP
        (NP (DT an) (NN immunoblot))
        (PP (IN for)
          (NP (NN IκB-α)
            (CC and)
            (NN actin))))
      (PP (IN at)
        (NP (DT the) (JJ same) (NN time))))
    (. .)))

(ROOT
  (NP
    (NP (NNP Table) (CD 1))
    (: :)
    (NP
      (NP (NN Production))
      (PP (IN of)
        (NP
          (NP
            (ADJP (JJ interleukin-17)
              (PP (IN in)
                (NP (NN response)))
              (PP (TO to)
                (VP
                  (ADJP (JJ anti-CD3)
                    (CC and)
                    (JJ mitogens))
                  (PP (IN by)
                    (NP (JJ peripheral) (NN blood))))))
            (NN mononuclear) (NNS cells)
            (CC and)
            (NNP T) (NNS cells))
          (PP (IN from)
            (NP
              (NP (NNS patients))
              (PP (IN with)
                (NP (JJ rheumatoid) (NN arthritis))))))))))

